Stockwinners Market Radar for February 02, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
GLBE | Hot Stocks20:15 EST Cathie Wood's ARK Investment bought 213K shares of Global-e Online today
|
SQ | Hot Stocks20:13 EST Cathie Wood's ARK Investment bought 549K shares of Block today
|
CCMP | Hot Stocks19:03 EST CMC Materials backs FY22 adjusted EBITDA view $355M-$385M - The company is reiterating full fiscal 2022 guidance, which includes Adjusted EBITDA to be between $355 million to $385 million, depreciation and amortization to be between $50 million to $55 million, tax rate to be between 20% to 23%, and capital spending to be between $60 million to $80 million. Interest expense is now expected to be between $38 million to $40 million.
|
WM | Hot Stocks18:25 EST Waste Management CEO: We saw about 9% labor inflation in Q4 - In an interview on CNBC's Mad Money, Jim Fish said Waste Management is definitely seeing inflation, but it's doing a good job of covering the increased costs. The company has been investing in technology for years to increase automation and reduce high-turnover positions, he noted. 70% of Waste Management's trucks now run on natural gas, he added. Revenue growth is all organic and the business is generating "a ton of cash," he said.
|
LSPD | Hot Stocks18:12 EST Lightspeed names JP Chauvet as CEO - Lightspeed announced that as part of its long-term succession planning process, the Lightspeed board of directors has appointed current President JP Chauvet to the role of CEO, effective immediately. He will lead Lightspeed's continued growth, strategic development and execution. The company also announced that Founder and outgoing CEO Dax Dasilva will continue to serve Lightspeed as Executive Chair of Lightspeed's board of directors. Chauvet joined Lightspeed in October 2012 as Chief Revenue Officer and became a board member in September 2013.
|
AMZN | Hot Stocks18:00 EST Amazon Labor Union files petition for union election at second NYC warehouse - The Amazon Labor Union tweeted that the group has officially filed a petition for union election at a second warehouse, LDJ5 in Staten Island, New York. "This is an amazing moment in history, seeing amazon workers finally taking the brave steps to make their voices heard," the group said. The move comes as the National Labor Relations Board is set to start sending ballots this week to around 6,100 workers at Amazon's Bessemer, Alabama facility over a union vote, according to media reports. Reference Link
|
BEAT | Hot Stocks17:23 EST HeartBeam enters pact with Livmor to build remote patient monitoring solution - HeartBeam announced it has signed a partnership agreement with Livmor, a digital health solutions company, to build a HeartBeam branded version of Livmor's Halo+ FDA cleared turnkey solution for remote patient monitoring to connect physicians and patients. Under the terms of the agreement Livmor will develop a HeartBeam branded version, the HeartBeam Platform, of the Livmor RPM platform customized for HeartBeam products, with senior executives of both companies supervising the project.
|
SLCA | Hot Stocks17:16 EST U.S. Silica increasing prices on industrial and specialty products - U.S. Silica announced that a portion of its Industrial and Specialty Products business will increase prices for the majority of its non-contracted engineered clay products used primarily in edible oil, industrial oil and petrochemical processes. Price increases will range up to 15%, depending on the product and grade. The price increases are effective for shipments starting March 1. This increase is driven by ongoing inflationary pressures around raw materials, packaging, logistics and maintenance expenses.
|
FB | Hot Stocks17:16 EST Meta Platforms says expects pressure on impression growth in the near term - Says Tik Tok is growing very quickly. Says focus on Reels important over long term. Says short form video will be an increasing part on how people consume content. Says investing in simplifying video across Instagram. Says building new tools to make buying online easier. Says making good progress on commerce efforts. Says due to iOS changes and European regulation, less data is available to deliver personalized ads. Says working on privacy infrastructure project. Says AI return on investment is stronger than expected. Says experiencing real traction with Quest 2. Says had strong holiday season. Says working on releasing high-end VR headset later this year. Says will launch Horizon on mobile later this year. Comments taken from Q4 earnings conference call.
|
BSM | Hot Stocks17:04 EST Black Stone Minerals increases distribution 8% to 27c per unit - Black Stone Minerals has approved a cash distribution for common units attributable to 4Q21 of 27c per unit, an increase of approximately 8% over the common distribution paid with respect to the prior quarter and a 54% increase relative to the distribution paid with respect to 4Q20. Distributions will be payable on February 23 to unitholders of record on February 16.
|
SEE | Hot Stocks17:01 EST SEE acquires Foxpak, terms not disclosed - SEE announced the acquisition of Foxpak Flexibles Ltd. under SEE Ventures, its initiative for investing in disruptive technologies and business models to accelerate growth. Foxpak, a privately-owned Irish packaging solutions company, pioneered the development of digital printing on flexible packaging. Foxpak partners with leading brands to deliver highly decorated packaging solutions; stand-up and spout pouches, and sachets that serve a variety of markets including food retail, pet food, seafood, and snacks. "Foxpak will build on our digital packaging solutions where graphic design and digital printing are key areas of value creation. Foxpak is recognized as a customer-centric, digital printing pioneer," said Ted Doheny, President and CEO at SEE. "Together we will accelerate our digital future with innovations in smart packaging for leading brands around the world." Terms of the deal have not been disclosed given this transaction is not material to SEE's financial results.
|
TMUS | Hot Stocks16:51 EST T-Mobile jumps 9% to $119.46 after Q4 earnings beat
|
SPOT | Hot Stocks16:49 EST Spotify falls 13% to $167.80 after Q4 earnings and guidance
|
HALO | Hot Stocks16:45 EST Halozyme names Nicole LaBrosse as CFO, succeeding Elaine Sun - Halozyme Therapeutics announced that Nicole LaBrosse has been promoted to the position of senior vice president, CFO, effective immediately. LaBrosse will succeed Elaine Sun, who is stepping down to pursue another opportunity. LaBrosse brings over 18 years of public accounting and corporate finance experience to Halozyme. LaBrosse joined Halozyme in 2015 and has since held roles of growing responsibility within the company. Prior to joining Halozyme, LaBrosse was with PricewaterhouseCoopers, LLP for over 10 years.
|
ETTX | Hot Stocks16:44 EST Entasis gets acquisition offer of $1.80 p/s for from majority holder Innoviva - Entasis Therapeutics announced that its Board of Directors received a preliminary, non-binding proposal from its majority stockholder Innoviva, to acquire all of the outstanding equity securities of Entasis that are not currently owned by Innoviva for a per share consideration of $1.80 payable in cash. The offer letter delivered by Innoviva to the Board of Directors is publicly available in the Schedule 13D amendment dated February 1, filed by Innoviva with the Securities and Exchange Commission. The Board of Directors of Entasis, which does not include any members appointed by or affiliated with Innoviva, has retained MTS Health Partners, L.P. and Covington & Burling to explore alternatives and to assist the board of directors in its evaluation of the proposal consistent with its fiduciary duties.
|
TBNK | Hot Stocks16:43 EST Territorial Bancorp announces $5M share repurchase program - Territorial Bancorp announces that its Board of Directors has adopted an eleventh stock repurchase program. Under this repurchase program, the company may repurchase up to $5,000,000 of the company's outstanding shares. Allan Kitagawa, Chairman and CEO, said, "As our economy recovers from effects of the pandemic, we are pleased to announce our eleventh stock repurchase program. We continue to have confidence in our economy as it extends its recovery."
|
BKU | Hot Stocks16:37 EST BankUnited announces $150M share repurchase plan - On February 2, the company's Board of Directors authorized the repurchase of up to $150M in shares of its outstanding common stock. No time limit was set for the completion of the share repurchase program, and the program may be suspended or discontinued without prior notice at any time.
|
HST | Hot Stocks16:35 EST Host Hotels buys Hotel Van Zandt for $246M, divests Sheraton Boston for $233M - Host Hotels announced that it has acquired the fee simple interest in the Hotel Van Zandt, a 319-room luxury lifestyle hotel in Austin, Texas for a purchase price of approximately $246M including its $4M FF&E reserve. The net acquisition price of approximately $242M represents a 13.2x multiple on 2019 EBITDA and stabilization is expected in the 2025-2027 timeframe at approximately 10-12x EBITDA. The company funded the acquisition with approximately $140M in proceeds from recent dispositions, and it assumed approximately $101.5M of existing secured debt. The debt matures in 2027, and the interest rate is fixed at an annual rate of 4.67%. This recently constructed hotel opened in 2015 with rooms that range in size from 330 to 1,100 square feet, including 52 suites. The hotel offers 13,000 square feet of indoor meeting space and three F&B outlets including a rooftop pool bar and a full-service restaurant with a stage and nightly live music. Hotel Van Zandt is well-located in Austin's Rainey Street district, the most popular entertainment district in the downtown area. Bolstered by the relocation of several Fortune 500 company headquarters, Austin is the third fastest growing city of the last decade and its population is projected to grow another 30% by 2029. The Rainey Street submarket is poised to benefit from several nearby mixed-use developments currently under construction or in planning, as well as the $1.2B expansion of the convention center, situated within walking distance of the hotel. In addition to the Hotel Van Zandt acquisition, the company also announced that it has sold the 1,220-room Sheraton Boston for approximately $233M. The sale price represents a 14.2x EBITDA multiple on 2019 EBITDA, which includes approximately $135M of estimated foregone capital expenditures over the next five years. In connection with the sale, the company is providing a $163M bridge loan to the purchaser.
|
TBNK | Hot Stocks16:35 EST Territorial Bancorp reopening Pearl City and Kalihi branches - Territorial Savings Bank announced that it plans to reopen its Pearl City and Kalihi Branches on Monday, February 7. The branches were temporarily closed in January due to staffing challenges related to COVID. "We are grateful to our staff and customers who diligently wear masks and practice social distancing while in our branches. Their care and compassion for each other helped us to quickly recover from the impact of COVID last month," explained Robert Lee, Senior Vice President of Banking Services. "We want to remind our customers that we offer contact-free banking such as mobile banking, online banking and phone banking so customers can bank safely from home or their office," added Lee Territorial Savings Bank began in 1921 offering home loans and savings accounts to the people of Hawaii. Today, with 29 branches on Oahu, Maui, Hawaii and Kauai, Territorial Savings Bank offers a full array of residential mortgage loans and attractive rates on checking and savings accounts
|
AIRI | Hot Stocks16:34 EST Air Industries wins $2.4M long-term parts agreement for Blackhawk helicopters - Air Industries Group announced that its Long Island-based subsidiary, Air Industries Machining Corp., has been awarded a Long-Term Agreement to manufacture flight-critical products for the Blackhawk helicopter. The estimated value of the LTA is $2.4M.
|
MTOR PCAR | Hot Stocks16:34 EST Meritor, Paccar extend electrification agreement - Meritor (MTOR) announced an extension to its current Paccar (PCAR) agreement to supply 14Xe ePowertrains and battery electric vehicle integration kits for the Class 8 Kenworth T680E, and Peterbilt 579EV tractors and 520EV refuse trucks. The integrated, modular design of the 14Xe ePowertrain, Power Controls and Accessories and Energy Storage System helps enable Paccar to meet the needs of its customers with high efficiency, performance and range depending on duty cycle and application requirements.
|
OHI | Hot Stocks16:33 EST Omega Healthcare not providing FY22 earnings guidance amid pandemic - Given the continued uncertainty related to the COVID-19 pandemic, its impact on the financial performance of the Company's operators and the extent of future necessary government support to the operators, the Company will not be providing 2022 earnings guidance.
|
BW | Hot Stocks16:32 EST Babcock & Wilcox acquires FPS, terms not stated - Babcock & Wilcox "announced that it has acquired Fossil Power Systems, a designer and manufacturer of hydrogen, natural gas and renewable pulp and paper combustion equipment including ignitors, plant controls and safety systems based in Dartmouth, Nova Scotia, Canada. The transaction closed February 1, 2022."
|
MTOR WNC | Hot Stocks16:32 EST Meritor extends long-term agreement with Wabash - Meritor (MTOR) announced that its long-term agreement with Wabash (WNC) has been extended through December 31, 2026. The extension is Meritor's first-ever five-year agreement with Wabash. Under the newly signed agreement, Meritor loose axles will continue to be standard equipment. Meritor Tire Inflation System will remain a preferred option in all Wabash configurations. In addition, Meritor's lightweight MTA-Tec6 and MPA suspensions, EX+ LS air disc brakes, and automatic slack adjusters will be available as data book options.
|
XL | Hot Stocks16:31 EST XL Fleet CFO Cielo Hernandez resigns - XL Fleet "announced that Cielo Hernandez has resigned as CFO of the Company as of January 31, 2022, to pursue other career opportunities. Ms. Hernandez's departure is not related to any disagreement with the Company over its accounting principles or practices, or financial statement disclosures. Chris Goldner, XL Fleet's Corporate Controller, has been appointed to serve as Interim Chief Financial Officer, effective February 1, 2022, while the Company undertakes a search for a permanent successor. Mr. Goldner has over twenty years of financial leadership experience with responsibilities including SEC reporting, accounting policies and procedures, and internal controls. He has served as XL Fleet's Corporate Controller since August 2021, with responsibility for leading the Company's accounting and reporting functions."
|
FB META | Hot Stocks16:28 EST Meta Platforms extends decline, now down 23% following earnings - Shares of Meta Platforms are down $73.95, or 23%, to $249.05 in after-hours trading following the release of the company's earnings report and ahead of its associated conference call.
|
ALL | Hot Stocks16:28 EST Allstate reports Q4 underlying combined ratio 91.3 vs. 79.1 last year - Reports Q4 Premiums written $10.3B vs. $8.6B last year.
|
CHNG UNH | Hot Stocks16:19 EST Change Healthcare will no longer provide guidance amid OptumInsight transaction - On January 5, 2021, OptumInsight, a diversified health services company and part of UnitedHealth Group (UNH), and Change Healthcare (CHNG) agreed to combine. Under the terms of the merger agreement, UnitedHealth Group, through a wholly-owned subsidiary, will acquire all of the outstanding shares of Change Healthcare common stock for $25.75 per share in cash. The Boards of Directors of both UnitedHealth Group and Change Healthcare have unanimously approved the terms of the Merger. At a special meeting held April 13, 2021, Change Healthcare stockholders voted to approve the Merger. Of the approximately 222 million shares voted, 99.9% voted in favor of the adoption of the merger agreement. The closing of the Merger is subject to applicable regulatory approval and other customary closing conditions. As previously disclosed, on March 24, 2021, the company and UnitedHealth Group each received a request for additional information and documentary materials from the Department of Justice in connection with the DOJ's review of the Merger, and on August 7, 2021, the parties entered into a timing agreement with the DOJ pursuant to which they agreed not to consummate the Merger before 120 days following the date on which both parties certified substantial compliance with the Second Request. Both the Company and UnitedHealth Group have now certified substantial compliance with the Second Request. On November 1, 2021, the Company and UnitedHealth Group entered into an amendment to the Timing Agreement with the DOJ pursuant to which they agreed not to consummate the Merger before 12:01 a.m. Eastern Time on February 22, 2022, unless they have received written notice from the DOJ prior to such date that the DOJ has closed its investigation. The parties have been working cooperatively with the DOJ and will continue to do so. On December 9, 2021, UnitedHealth Group delivered written notice to the Company that it was exercising its unilateral right to extend the Outside Date to April 5, 2022.
|
COST | Hot Stocks16:18 EST Costco reports January sales of $15.76B, up 15.5% - Reports January comparable sales up 14.2%. Reports January e-commerce comparable sales up 9%. For the twenty-two weeks ended January 30, the company reported net sales of $92.1B, an increase of 16.4% from $79.11B last year.
|
GHL | Hot Stocks16:16 EST Greenhill & Co. doubles quarterly dividend to 10c per share - The dividend is payable on March 16, 2022 to common stockholders of record on March 2, 2022.
|
FB | Hot Stocks16:16 EST Meta Platforms down 18% after earnings and guidance miss - Shares of Meta are down $59.51, or 18%, to $263.49 in after-hours trading.
|
FB | Hot Stocks16:15 EST Meta Platforms down 18% after earnings and guidance miss - Shares of Meta are down $59.99, or 19%, to $263.01 in after-hours trading.
|
FLEX | Hot Stocks16:14 EST Flex to sell $500M of convertible preferred equity in Nextracker to TPG Rise - Flex announced that it has entered into an agreement to sell $500M of convertible preferred equity in Nextracker to TPG Rise Climate, the dedicated climate investing strategy of TPG's global impact investing platform TPG Rise. Through this strategic partnership and investment from TPG Rise Climate, Nextracker will continue to expand its market leading position in solar tracking and software solutions. TPG's experience and extensive network in renewable energy provide Nextracker a strong partner to support long-term growth. As part of the investment, Coslet and Mandel will join the Nextracker board. The investment is at an implied enterprise value for Nextracker of $3B, in the form of a convertible preferred security with a 5.0% annual dividend. The convertible preferred security will convert into common equity of Nextracker at the time of a qualified initial public offering for Nextracker. Net proceeds from the transaction will be used to help fund growth and generate returns for Flex shareholders in accordance with its capital allocation policy. Flex and Nextracker have also entered into a separation agreement to formally separate the operations of the two businesses and have agreed to a transition services agreement to efficiently transition the Nextracker business into a separate business. Flex will report the Nextracker business as a separate operating segment in the future. Nextracker confidential S-1 remains on file with the SEC. The initial public offering and its timing are subject to market and other conditions and the SEC's review process.
|
NTGR | Hot Stocks16:11 EST Netgear sees Q1 GAAP operating margin (1.5%)-(0.5%), GAAP tax rate (29%)
|
RKLB | Hot Stocks16:11 EST Rocket Lab to expand Colorado footprint with new space systems complex - Rocket Lab USA announced it will open a new space systems complex in Littleton, Colorado to support growing customer demand for flight software, mission simulation, and Guidance, Navigation and Control services. The new complex expands on Rocket Lab's existing footprint in Colorado, which was established in October 2021 with the acquisition of Advanced Solutions, Inc., an aerospace engineering firm that develops industry-leading software and technology solutions for reliable space mission design and operation. ASI's off-the-shelf spacecraft flight software, MAX, has been operating across 49 spacecraft for a cumulative 135 years in space supporting missions for leading aerospace prime contractors, the U.S. Air Force, U.S. DOD organizations, NASA, and commercial spacecraft developers. The new complex will be established near Rocket Lab's existing 15,000 sq ft location on Shaffer Parkway in Littleton and will add 40,000 sq ft of new lab, production, and office space. The complex is expected to be completed by late 2022 and will include two mission operations centers. The expansion will also support team growth, with Rocket Lab's Colorado headcount expected to double to more than 120 people by early 2023 with roles spanning flight software development, GNC, spacecraft simulation, and systems engineering.
|
FB... | Hot Stocks16:11 EST Meta Platforms sees trading on Nasdaq under ticker 'META' in first half of 2022 - Meta said its Class A common stock is expected to begin trading on NASDAQ under the ticker symbol "META" in the first half of 2022. This will replace the current ticker symbol "FB," which has been used since the company's initial public offering in 2012, and more details on exact timing will be forthcoming. "No action is required by our stockholders with respect to the ticker symbol change and it does not affect the rights of our stockholders. Our Class A common stock will continue to be listed on NASDAQ and the CUSIP number will remain unchanged," the company stated.
|
RKDA... | Hot Stocks16:11 EST Arcadia Biosciences names Stan Jacot as CEO - Arcadia Biosciences (RKDA) has appointed veteran consumer goods leader Stan Jacot as CEO, effective Feb. 2. Jacot holds an impressive track record of implementing transformational business strategies and profitably driving growth, most recently at Jane's Dough Foods where he achieved a double-digit compound annual growth rate during his six-year tenure. Previously, Jacot held senior marketing and operations roles at Mission Foods, Borden Dairy Company, ConAgra Foods (CAG) and Kellogg Company (K) across the U.S. and Canada.
|
HTBX | Hot Stocks16:10 EST Heat Biologics to transfer listing to NYSE from Nasdaq - Heat Biologics announced that it plans to change its listing from Nasdaq to the NYSE American stock exchange. Heat expects to commence trading as an NYSE American-listed company when markets open on Monday, February 14. The company's common stock will continue to trade under its existing (HTBX) symbol. The company will continue to trade on Nasdaq Cuntil the close of market on Friday, February 11.
|
FB MVRS | Hot Stocks16:09 EST Meta Platforms expect 2022 total expenses in range of $90B-$95B - Meta Platforms said: "We expect 2022 total expenses to be in the range of $90-95 billion, updated from our prior outlook of $91-97 billion. Our anticipated expense growth is driven by investments in technical and product talent and infrastructure-related costs. We expect 2022 capital expenditures, including principal payments on finance leases, to be in the range of $29-34 billion, unchanged from our prior estimate. Our planned capital expenditures are primarily driven by investments in data centers, servers, network infrastructure, and office facilities. As we discussed previously, this range reflects a significant increase in our artificial intelligence and machine learning investments, which will support a number of areas across our Family of Apps. While our Reality Labs products and services may require more infrastructure capacity in the future, they do not require substantial capacity today and, as a result, are not a significant driver of 2022 capital expenditures. Absent any changes to U.S. tax law, we expect our full-year 2022 tax rate to be similar to the full-year 2021 rate."
|
HWKN | Hot Stocks16:09 EST Hawkins increases quarterly cash dividend 8% to 14c per share - The board of directors of Hawkins increased its quarterly cash dividend 8% to 14c per share payable March 4 to shareholders of record at the close of business on February 18. With this increase, the dividend has been increased by 14% over the last 12 months. Hawkins has consistently paid out a dividend since 1985.
|
AFL | Hot Stocks16:08 EST Aflac reiterates 21.2% increase in Q1 cash dividend - The board of directors declared the first quarter dividend of 40c per share, payable on March 1 to shareholders of record at the close of business on February 16.
|
FB MVRS | Hot Stocks16:08 EST Meta reports Facebook MAUs of 2.91B as of Dec. 31, up 4% year-over-year - Meta Platforms reports family daily active people, or DAP, was 2.82 billion on average for December 2021, an increase of 8% year-over-year. Family monthly active people, or MAP, was 3.59 billion as of December 31, 2021, an increase of 9% year-over-year. Facebook daily active users, or DAUs, were 1.93 billion on average for December 2021, an increase of 5% year-over-year. Facebook monthly active users, or MAUs, were 2.91 billion as of December 31, 2021, an increase of 4% year-over-year.
|
IMUX | Hot Stocks16:07 EST Immunic receives Notice of Allowance for patent application 16/644581 - Immunic announced that the company received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application 16/644581, entitled, "IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation". The company also received notice of allowance of patent application EP18762111.5 in Europe, and notice of grant of patent application 2018330633 in Australia. All three patents cover composition-of-matter of IMU-935 and related formulations, and are expected to provide protection into at least 2038, without accounting for potential Patent Term Extension in the United States or Supplementary Protection Certificates in Europe, respectively.
|
TMUS | Hot Stocks16:06 EST T-Mobile sees FY22 core adjusted EBITDA $25.6B-$26.1B - Sees FY22 postpaid net customer additions 5M-5.5M. Sees FY22 capex $13B-$13.5B.
|
FB MVRS | Hot Stocks16:06 EST Meta reports Facebook DAUs 1.93B on average for December, up 5% year-over-year
|
SYRS | Hot Stocks16:05 EST Syros Pharmaceuticals gets FDA orphan drug designation for Tamibarotene in MDS - Syros Pharmaceuticals "announced that the U.S. Food and Drug Administration has granted orphan drug designation to tamibarotene for the treatment of myelodysplastic syndrome, or MDS. Tamibarotene, an oral first-in-class selective retinoic acid receptor alpha agonist, is currently being evaluated in combination with azacitidine in the SELECT-MDS-1 Phase 3 trial for RARA-positive patients with newly diagnosed higher-risk MDS".
|
CTSH | Hot Stocks16:03 EST Cognizant raises quarterly dividend 12% to 27c per share - On February 2, the company declared a quarterly cash dividend of 27c per share, a 12% increase, for shareholders of record on February 18. This dividend will be payable on March 1.
|
SPOT | Hot Stocks16:03 EST Spotify sees Q1 MAUs 418M - Sees Q1 premium subscribers 183M. Sees Q1 revenue EUR2.6B. "We are re-aligning our current guidance practice to better reflect how we run the business," the company said. "Since the vast majority of our initiatives are multi-year in nature and measured as such, we no longer plan to issue annual guidance. However, we intend to utilize quarterly guidance as checkpoints against our progress and will provide additional thoughts and perspective around 2022 expectations on our earnings call. As for quarterly guidance, going forward we will simplify our approach by providing a single estimate for each metric instead of a range of outcomes. Additionally, we plan to host an investor day later in 2022 to offer an update on the strength of our platform and our advancement towards our long-term operating goals."
|
PYR | Hot Stocks14:25 EST PyroGenesis announces receipt of C$4M purchase order - PyroGenesis Canada announces, further to its press release dated June, 7 2021, it has entered into an agreement with an existing client to purchase the first of three 10,000 TPY Drosrite systems. The contract is for $3M, or approximately C$4M, and the client's name "shall remain anonymous for competitive and confidential reasons," PyroGenesis said.
|
ABBV VTRS | Hot Stocks13:48 EST FDA approves first generic of AbbVie's Restasis - The U.S. Food and Drug Administration has approved the first generic of Restasis 0.05% single-use vials to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca, commonly known as dry eye. "Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug that can help the millions of Americans who suffer from dry eyes. Today's approval reflects the FDA's continued commitment to advancing patient access to lower-cost, high-quality generic drug products that are as safe and effective as their brand name counterparts. Supporting development and expanding opportunities to bring complex generic drugs to the market is a major focus of our efforts to help improve competition and help lower drug prices," said Sally Choe, Ph.D., director of the Office of Generic Drugs in FDA's Center for Drug Evaluation and Research. The sponsor of the generic cyclosporine ophthalmic emulsion 0.05% single-use vials approved today is Mylan Pharmaceuticals, a unit of Viatris (VTRS). Cyclosporine ophthalmic emulsion is marketed under the trade name Restasis by Allergan, an AbbVie (ABBV) company.
|
ABBV VTRS | Hot Stocks13:43 EST Viatris' Mylan granted approval for first generic of AbbVie's Restasis - The FDA has announced that it approved the first generic of Restasis 0.05% single-use vials, which are marketed under the brand name by AbbVie (ABBV) to increase tear production. The sponsor of the abbreviated new drug application, or ANDA, approved by the FDA is Mylan Pharmaceutical, which is owned by Viatris (VTRS).
|
CNI... | Hot Stocks13:43 EST North American rail traffic dropped 6.3% in week ended January 29 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending January 29. Total U.S. weekly rail traffic was 491,868 carloads and intermodal units, down 5.6% compared with the same week last year. Total carloads for the week ending January 29 were 235,203 carloads, up 1.5% compared with the same week in 2021, while U.S. weekly intermodal volume was 256,665 containers and trailers, down 11.3% compared to 2021. North American rail volume for the week ending January 29, on 12 reporting U.S., Canadian and Mexican railroads totaled 330,400 carloads, down 1.5% compared with the same week last year, and 337,564 intermodal units, down 10.6% compared with last year. Total combined weekly rail traffic in North America was 667,964 carloads and intermodal units, down 6.3%. North American rail volume for the first four weeks of 2022 was 2,562,997 carloads and intermodal units, down 10.9% compared with 2021. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC) Union Pacific (UNP) Greenbrier (GBX) Trinity Industries (TRN, ) FreightCar America (RAIL) and Wabtec (WAB). Reference Link
|
NSRGY | Hot Stocks13:31 EST Butterfly announces agreement to sell majority stake in Orgain to Nestle - Butterfly, a Los Angeles-based private equity firm specializing in the food sector, announced that Nestle Health Science has agreed to acquire a majority stake in its portfolio company Orgain, a U.S. plant-based functional nutrition platform. Butterfly and Dr. Andrew Abraham, Orgain's Founder and CEO, will retain significant minority ownership positions in the company. Dr. Abraham will continue to lead the company as CEO. Terms of the deal were not disclosed. Orgain Founder and CEO Dr. Abraham said: "Today, in partnering with Nestle Health Science, we take a giant leap forward in pursuing that mission of providing accessible, healthy nutrition for all. Nestle Health Science shares that mission and will help us to get better, cleaner nutrition products into the hands of more consumers than I ever imagined possible when I founded this company twelve years ago."
|
ADOC | Hot Stocks13:10 EST Edoc Acquisition Corporation (Class A Stock) trading resumes
|
AEG C | Hot Stocks13:04 EST Aegon to appoint Deborah Waters as Chief Technology Officer - Deborah Waters joins Aegon (AEG) from Citigroup (C), where she held various technology leadership positions. Most recently she served as Citi's Global Head of Private Bank Operations and Technology. Additionally, Deborah was the Head of Inclusion and Diversity for Citi's Institutional Client Group Operations and Technology.
|
XRX | Hot Stocks13:02 EST Xerox acquires Canadian IT services provider Powerland - Xerox Holdings announced it has acquired Powerland, an IT services provider in Canada, for cash. "The acquisition strengthens Xerox's IT services offerings in North America, which include cloud, cyber security, end user computing and managed services. Powerland serves customers throughout Canada and provides a wide array of technology solutions and services including cloud, hybrid cloud, cyber security, and end-user computing solutions based on individual business needs... Recent research shows that SMBs will increase their investments in key IT solutions such as cloud infrastructure, managed IT services, collaboration solutions and cyber security. The addition of Powerland will enable Xerox to expand reach in North America to offer increased value to customers throughout Canada," the company stated.
|
ADOC | Hot Stocks12:44 EST Calidi Biotherapeutics to come public via merger with Edoc Acquisition - Calidi Biotherapeutics, a clinical-stage biotechnology company working on the development of cell-based delivery of oncolytic viruses, and Edoc Acquisition Corp. (ADOC), a blank check company organized to acquire or merge with one or more businesses, have entered into a definitive merger agreement. Upon closing the transaction, anticipated to occur in the second quarter of 2022, the combined company will be named Calidi Biotherapeutics, Inc. and led by Allan Camaisa, CEO and Chairman of the board. In addition, the combined company's common stock intends to list on the Nasdaq Capital Market. Allan Camaisa said: "This business combination positions us well as we enter the next phase of our growth, delivering on the promise of our NeuroNova and SuperNova platforms, to surpass the deficiencies of the first generation oncolytic viruses existing in the marketplace. Furthermore, it will allow us to leverage Edoc's extensive 400+ physician network across many disciplines." The transaction includes gross proceeds of up to $92M in trust at Edoc, less any redemptions by existing Edoc shareholders, and a concurrent $25M PIPE from institutional investors. Additionally, Edoc entered into backstop arrangements with certain institutional investors for the purchase of up to 2.2 million shares of Edoc Class A ordinary shares in connection with Edoc's shareholder meeting to approve the business combination as well as Edoc's February 9, 2022 shareholder meeting to approve an extension of time to complete its business combination, with the actual amount dependent upon the amount of cash available after each such shareholder meeting after any redemptions. Net proceeds from the transaction are expected to provide Calidi with capital to advance its pipeline through multiple clinical milestones. Upon closing of the business combination, and assuming no redemptions of shares of Edoc by its public shareholders, Calidi would be expected to have cash and cash equivalents, prior to transaction expenses, of approximately $117M, less any redemptions and transaction expenses, and a pro forma enterprise valuation of $449M. The boards of directors of Calidi and Edoc unanimously approved the proposed transaction, which is anticipated to close in the second quarter of 2022. The closing of the transaction is subject to the approval of Edoc shareholders, regulatory approval and the satisfaction or waiver of certain other customary closing conditions.
|
F RUN | Hot Stocks12:11 EST Ford, Sunrun partner to advance home enrgy storage with F-150 Lightning truck - Ford (F) and Sunrun (RUN) are partnering to advance home energy storage and solar power using the F-150 Lightning truck to power homes and help accelerate the adoption of zero-carbon solar energy, the companies said in a statement. "F-150 Lightning brings new innovations to customers, including the ability to power their homes when they need it most," said Matt Stover, Ford charging and energy services director. "Teaming up with Sunrun leverages their expertise to bring solar power to even more customers, giving them the chance to turn their truck into an incredible energy storage source - and future truck features can help accelerate the development of a less carbon-intensive grid." Sunrun is the preferred installer of F-150 Lightning home charging solutions, including the 80-amp Ford Charge Station Pro and Home Integration System, which enables the F-150 Lightning to store and supply power to homes in a variety of ways. Sunrun will also offer home solar options to customers in select areas who are interested in leveraging more renewable energy.
|
PRGO | Hot Stocks12:04 EST California, 10 district attorneys settle with Perrigo over formula safety - California Attorney General Rob Bonta, along with 10 district attorneys, announced a settlement with Perrigo and two of its subsidiaries to improve the safety of the company's infant and toddler formula products by putting in place ingredient sourcing and quality control processes to reduce levels of lead. In 2018, the Attorney General filed a lawsuit against Perrigo after testing showed that its infant and toddler formula products contained levels of lead that exceeded the Proposition 65 warning threshold. Today's settlement sets maximum lead levels of 5-7 parts per billion for most of these products, levels much lower than applicable guidance levels established for this type of product by any U.S. regulatory authority. Reference Link
|
ONVO | Hot Stocks12:03 EST Organovo says two patents withstood patent challenge - Organovo Holdings announced that two of its patents have withstood a patent challenge, and the company provided guidance on how it expects to leverage its patent portfolio. The company said, "Organovo holds a powerful foundational patent portfolio in the 3D bioprinting space due to its licensing of pioneering work in the field and early innovations beyond that start. Organovo is focused today on bringing inflammatory bowel disease drugs to market, with multiple IND filings expected by 2025. However, the company plans to utilize licensing revenue from its patent strength to help fund development costs of new drugs. The company currently expects to achieve millions of dollars of revenue over FY2022 to FY2025 combined from licensing its patents within the field. The strength of its patents and growth in the bioprinting industry have made for an attractive business opportunity for the company. Organovo will now begin to invest resources to explore and expand business and revenue opportunities in this area. Organovo exclusively licensed early bioprinting work by Gabor Forgacs, its scientific founder, and Thomas Boland of Clemson, both bioprinting pioneers. After its founding, the company went on to innovate broadly and obtain a broad set of patents that provide formidable foundational claims in the bioprinting space. Third parties recognized Organovo's bioprinting IP as foundational and innovative as far back as 2015. Two Organovo patents recently stood up to a major challenge. A challenger filed petitions for inter partes review with the Patent Trial and Appeal Board in the US Patent and Trade Office, asking the PTAB to invalidate those patents' claims as obvious. The PTAB rejected the challenges and refused to institute proceedings, which means that the PTAB did not think it was likely that the challenges would be successful. There is no appeal from these decisions. Further, the patents are even stronger now that they have been tested."
|
SHOP | Hot Stocks12:01 EST Shopify falls -11.8% - Shopify is down -11.8%, or -$116.17 to $868.03.
|
SQ | Hot Stocks12:01 EST Block falls -12.2% - Block is down -12.2%, or -$15.54 to $112.07.
|
CMCSA... | Hot Stocks12:01 EST Comcast, ViacomCBS announce full regulatory approval for SkyShowtime - Comcast Corporation (CMCSA) and ViacomCBS Inc. (VIACA), announced that SkyShowtime, their new streaming joint venture, has received full regulatory approval and plans to launch in more than 20 European markets encompassing 90 million homes starting later this year. SkyShowtime CEO Monty Sarhan, said, "We are pleased that SkyShowtime has received all regulatory approvals and are excited to bring this new, unique and compelling entertainment service-with a broad range of some of the world's leading content-to millions of consumers across these markets." SkyShowtime will ultimately be available in the following markets: Albania, Andorra, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Kosovo, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, and Sweden.
|
DT | Hot Stocks12:01 EST Dynatrace falls -20.4% - Dynatrace is down -20.4%, or -$11.51 to $44.77.
|
LABD | Hot Stocks12:01 EST Daily S&P Biotech Bear 3x Shares rises 10.8% - Daily S&P Biotech Bear 3x Shares is up 10.8%, or $4.00 to $41.01.
|
SSU | Hot Stocks12:00 EST SIGNA Sports United rises 11.6% - SIGNA Sports United is up 11.6%, or 87c to $8.37.
|
ATI | Hot Stocks12:00 EST Allegheny Technologies rises 17.8% - Allegheny Technologies is up 17.8%, or $3.34 to $22.15.
|
BIMI | Hot Stocks11:44 EST BIMI International Medical announces 1-for-5 reverse stock split - BIMI International Medical announced a 1-for-5 reverse split of its common stock effective today at 5:00 PM EST. Beginning on February 3, the company's common stock will trade on Nasdaq on a split adjusted basis. The reverse stock split is intended to increase the per share trading price of the Company's ordinary shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split, the company will have approximately 8,502,221 ordinary shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants.
|
IAG | Hot Stocks11:33 EST IAMGold 'firmly rejects RCF's revisionist narrative' - IAMGOLD Corporation "set the record straight" on its recent engagement with RCF Management, a recent 5.2% shareholder, regarding negotiations between the parties over refreshment of the IAMGOLD board of directors. The Company will provide further updates as developments warrant. In the meantime, there is no need for shareholders to take any action. The company said, "IAMGOLD firmly rejects RCF's revisionist narrative regarding its engagement with the Company and the quality of its Board and management team. In fact, the Company engaged openly and constructively with RCF over a period of two weeks, including via meetings with management, Board members, and between legal counsel. IAMGOLD was transparent with RCF about its continuing board renewal process - including the planned departure of its former Board Chair and certain other directors. In an attempt to avoid the unnecessary cost and distraction of a proxy contest, at the Company's suggestion, the parties entered into a standstill agreement in order to provide requisite time to allow a committee of the Board, as well as the internationally renowned search firm engaged by the Board, to meet with and consider RCF's three director nominees in support of an acceptable resolution. After completing interviews with RCF's nominees, the committee of the Board and the search firm engaged by the Board independently concluded that two RCF nominees, Maryse Belanger and David Smith, were acceptable, and one, Lawrence Haber, was not. The Board was willing to immediately appoint these two acceptable RCF nominees, to replace two IAMGOLD directors. Further, the Board agreed to the appointment of a third independent RCF nominee that was to be reasonably acceptable to the Board. RCF had previously agreed to recommend another nominee, other than Mr. Haber, for appointment to IAMGOLD's Board...The Board was not willing to accept several overreaching and self-interested RCF demands that would have resulted in a recent 5.2% shareholder taking de facto control of the Company...The Company has additional concerns with RCF and its nominees, which it will disclose in due course, but shareholders can rest assured that the Company will continue to defend and advance the best interests of the Company and ALL of its shareholders."
|
HOG NKE | Hot Stocks11:03 EST Harley-Davidson appoints Louise Goldin as creative director - Harley-Davidson (HOG) announces the appointment of Erica Bullard as SVP of Apparel & Licensing and Louise Goldin as Creative Director. Today's announcement sees the strategic renaming of Harley-Davidson's General Merchandise function to Apparel & Licensing. This newly created function will leverage Harley-Davidson's recently opened creative studio in Tribeca, NYC, in addition to Harley-Davidson's established design studio and archive in Milwaukee. In this newly created role, reporting into Jochen Zeitz, CEO, Bullard will lead the global apparel and licensing business for the Harley-Davidson brand. Erica joins Harley-Davidson from global sportswear brand NIKE (NKE). Goldin will head the new studio and design teams in New York and Milwaukee, bringing her expertise in applying advanced technology and functionality to the intersection of modern lifestyle design and fit-for-purpose apparel at Harley-Davidson.
|
OMC | Hot Stocks11:02 EST Omnicom acquires omnichannel engagement marketing agency Propeller - Omnicom Health Group, part of Omnicom Group, announced it has acquired Propeller, which it identifies as "a digitally-focused omnichannel engagement marketing agency that specializes in healthcare." The company added: "The acquisition of Propeller follow's OHG's acquisition of Archbow in 2021 and is in line with the group's strategy to continue to invest in areas of rapid growth." President Charles Flax and the leadership team at Propeller will continue to serve in their current roles. Joshua Prince, CEO of the Professional Group for Omnicom Health Group, said: "We've known and admired Propeller's great work through several clients we share in the areas of major pharmaceuticals, medical devices and biotechnology. We're excited to welcome their talented staff of 'Propellers' to OHG. Charlie and his leadership team bring deep digital marketing expertise and solutions that will now be available to all our clients."
|
RDBX | Hot Stocks10:52 EST Redbox sinks after borrowing remaining funds under revolving credit facility - Shares of Redbox are down $2.40, or 45%, to $2.93 after the company disclosed in a regulatory filing earlier this morning that it has borrowed the remaining availability under its revolving credit facility. In the filing with the SEC, Redbox stated: "During 2021, Redbox Entertainment Inc.'s business was negatively impacted by the effects of the ongoing COVID-19 pandemic, which resulted in fewer releases on its platforms than management previously expected and materially lower financial results. During the fourth quarter of 2021, Redbox had 24 theatrical releases, which was lower than expected. In addition, the significant increase in impacts from the Omicron variant caused disruption to the business. As such, Redbox rentals have not recovered to the extent expected and, notwithstanding the year-over-year increase in new releases, were lower than the fourth quarter of 2020. Historically, rentals have been correlated with the number and quality of new theatrical titles released in a quarter. In support of its efforts to expand its business and transform into a multi-faceted entertainment company, during the fourth quarter of 2021 and into 2022, Redbox increased its marketing and on-demand expenditures. Costs also increased as Redbox purchased more content. During that period, increased costs have not been offset by an increase in revenues. Redbox's business has also experienced an increase in competition from new and existing competitors. On January 28, 2022, Redbox borrowed the remaining availability under its revolving credit facility. Redbox's primary sources of liquidity are cash on hand, cash flow generated from operations, and amounts available under its revolving credit facility. Management is actively taking steps to decrease monthly costs, delay capital expenditures, and increase revenues. Redbox is also evaluating a variety of strategic alternatives."
|
IDBA | Hot Stocks10:27 EST IDEX Biometrics ASA (ADS) trading resumes
|
IDBA | Hot Stocks10:22 EST IDEX Biometrics ASA (ADS) trading halted, volatility trading pause
|
EAT | Hot Stocks10:21 EST Brinker 'on track' with prior expectations for the full year, says CFO Taylor - Comments taken from Q2 earnings conference call.
|
CVLY | Hot Stocks10:06 EST Driver Management nominates 3 to Codorus Valley Bancorp board - Driver Management Company LLC, the beneficial owner of 6.72% of the outstanding shares of Codorus Valley Bancorp, issued a statement regarding its decision to nominate independent candidates for election to the company's Board of Directors at the 2022 Annual Meeting of Shareholders. Abbott Cooper, Driver's founder and managing member, commented: "Like many shareholders, we are unhappy with Codorus Valley's long-term underperformance. While Larry Miller was, in our opinion, a terrible Chief Executive Officer, simply replacing him with Craig Kauffman is not the answer. Mr. Kauffman has never been a CEO and brings limited experience as the officer of a public company. In our view, he has failed to communicate a viable plan to deliver value to long-suffering shareholders or acknowledge our concerns and, if the fourth quarter is any indication, Mr. Kauffman may prove to be even worse than Mr. Miller at creating shareholder value... Since June 2021, we have tried to engage the Board in a candid and frank discussion regarding Codorus Valley's performance and prospects. Rather than participate in serious discussions, the Board and Mr. Kauffman seem to prefer pointless conversations about vague, aspirational plans untethered to actual performance. In addition, despite our many requests, the Board has categorically refused to provide any information regarding executive compensation arrangements that we believe clearly create a conflict of interest between management and shareholders and were adopted without the requisite care. At this point, we feel compelled to nominate candidates who we believe can be agents of change in the boardroom and help unlock the significant value trapped within Codorus Valley's underperforming shares."
|
BAESY | Hot Stocks10:02 EST BAE Systems awarded $14M contract from IARPA to advance machine learning - BAE Systems has been awarded a $14M contract from the Intelligence Advanced Research Projects Activity to develop tools to decipher an ever-growing number of radio frequency signals in order to quickly and accurately help secure mission-critical information. BAE Systems will advance machine learning and artificial intelligence technology and techniques to identify signals in the RF spectrum under the terms of the contract, which is part of the Securing Compartmented Information with Smart Radio Systems program. The technology will provide enhanced situational awareness, help to target threats, and secure communications against malicious attacks.
|
PCYG | Hot Stocks10:02 EST Park City Group/ReposiTrak names Derek Hannum as chief customer officer - Park City Group/ReposiTrak has promoted Derek Hannum to the newly created role of Chief Customer Officer. Hannum most recently served as senior vice president of customer success, overseeing the company's marketing and customer success activities. In the new role, Hannum is responsible for expanding customer relationships, growth and revenue performance, including sales, marketing and customer success, the company said in a statement.
|
SQ | Hot Stocks10:00 EST Block falls -7.8% - Block is down -7.8%, or -$10.02 to $117.59.
|
BRFS | Hot Stocks10:00 EST BRF S.A. falls -9.4% - BRF S.A. is down -9.4%, or -39c to $3.74.
|
DT | Hot Stocks10:00 EST Dynatrace falls -20.5% - Dynatrace is down -20.5%, or -$11.54 to $44.74.
|
STAR | Hot Stocks10:00 EST iStar rises 8.5% - iStar is up 8.5%, or $1.87 to $23.96.
|
UNG | Hot Stocks10:00 EST United States Natural Gas Fund rises 8.9% - United States Natural Gas Fund is up 8.9%, or $1.52 to $18.62.
|
ABBV | Hot Stocks10:00 EST AbbVie expects operating margin expansion in FY22
|
ATI | Hot Stocks10:00 EST Allegheny Technologies rises 14.1% - Allegheny Technologies is up 14.1%, or $2.65 to $21.46.
|
GLW | Hot Stocks09:57 EST Corning raises quarterly dividend 12.5% to 27c from 24c per share - The dividend will be payable on March 30 to shareholders of record on Feb. 28.
|
ETTX INVA | Hot Stocks09:52 EST Innoviva submits non-binding proposal to acquire all of Entasis Therapeutics - Innoviva (INVA) on Tuesday submitted a non-binding proposal to acquire all outstanding shares of Entasis Therapeutics (ETTX) not owned by Innoviva for $1.80 per share. This represents a 23% premium to the closing price on January 31, Innoviva said in a regulatory filing, adding that "The Proposal contemplates that the acquisition would be conditioned on the independent members of the Issuer's Board of Directors, represented by independent legal and financial advisors, approving the transaction, and such transaction being approved by holders of a majority of the outstanding shares of the Issuer's capital stock owned or controlled by disinterested stockholders."
|
XRX | Hot Stocks09:47 EST Xerox JV Eloque announces plans to triple bridge installs in 1H22 - Xerox announced that Eloque, the joint venture between Xerox's Palo Alto Research Center and the Victorian Government, plans to triple the number of bridges in Australia using its fiber optic sensing technology during the first half of 2022, while also targeting expansion into the United States and Europe. "Eloque provides structure and bridge engineers, asset managers and public infrastructure leaders with the information they need on structural health to better prioritize maintenance, extend the life of infrastructure assets and serve as an early warning system for potential failures," said John Visentin, vice chairman and chief executive officer at Xerox. "Eloque is already seeing success with the installs in Australia and is working with multiple state departments of transportation in the U.S. to start deploying pilots in 2022, while continuing talks in select European countries."
|
SQ | Hot Stocks09:47 EST Block falls -8.0% - Block is down -8.0%, or -$10.21 to $117.40.
|
BRFS | Hot Stocks09:47 EST BRF S.A. falls -8.4% - BRF S.A. is down -8.4%, or -34c to $3.79.
|
DT | Hot Stocks09:47 EST Dynatrace falls -25.5% - Dynatrace is down -25.5%, or -$14.33 to $41.95.
|
EAT | Hot Stocks09:47 EST Brinker rises 11.8% - Brinker is up 11.8%, or $4.08 to $38.81.
|
ATI | Hot Stocks09:47 EST Allegheny Technologies rises 12.4% - Allegheny Technologies is up 12.4%, or $2.34 to $21.15.
|
STAR | Hot Stocks09:47 EST iStar rises 14.2% - iStar is up 14.2%, or $3.13 to $25.22.
|
ADOC | Hot Stocks09:44 EST Edoc Acquisition Corporation (Class A Stock) trading halted, news pending
|
WORX | Hot Stocks09:39 EST SCWorx signs customer agreement for new product offering - SCWorx Corp. announced that it has signed a 39 month agreement with an existing customer for a new product offering. The Agreement provides for approximately $1.1M in payments over the full contract term, subject to earlier termination in specified circumstances. This new agreement, which was effective October 1, 2021, expands the services that the Company is providing to its existing customer, a highly respected stand-alone academic health system located in the northeast.
|
GRPN | Hot Stocks09:38 EST Groupon holds 2.4% non-controlling ownership interest in SumUp - In a post to the FAQs page of its investor relations website, Groupon states: "Groupon, Inc. holds a 2.4% non-controlling ownership interest in SumUp Holdings S.a.r.l., or 'SumUp,' a privately-held, global payments service provider. Groupon has been a passive investor in SumUp since 2013. During the first quarter 2020, we sold 50% of our shares in SumUp for a total cash consideration of $34.0M. In the third quarter 2021, SumUp initiated a secondary equity offering, in which Groupon did not participate, and as a result we adjusted the carrying value of our investment that resulted in an unrealized gain of $89.1M, as of September 30, 2021. There is no public market for SumUp securities at this time. In addition, Groupon has non-controlling minority investments in Monster Holdings LP and Nearbuy Pte Ltd. Both of these investments had a fair value of $0.0 million as of September 30, 2021. Groupon also has non-controlling investments in various other entities." It is unclear when Groupon updated its website to reflect its investment holdings disclosures. Previously, on January 26, Bloomberg had reported that SumUp may seek new funds at a $22B valuation. Reference Link
|
MGM GMVHF | Hot Stocks09:30 EST BetMGM announces debut of new loyalty rewards program - BetMGM, a partnership between MGM Resorts International (MGM) and Entain Plc (GMVHF), announced the launch of BetMGM Rewards, stating that "BetMGM customers can now earn BetMGM Rewards Points and MGM Rewards Tier Credits that unlock VIP benefits to MGM Resorts' 20+ premier destination resorts from Bellagio, ARIA, MGM Grand and Mandalay Bay in Las Vegas; to Borgata in Atlantic City; Beau Rivage in Mississippi; and MGM National Harbor in Maryland, amongst many others." The company said BetMGM Rewards is currently available in the following markets - Colorado; Indiana; Iowa; Louisiana; Michigan; Mississippi; New Jersey; New York; Pennsylvania; Tennessee; Virginia; Washington, D.C.; West Virginia; and Wyoming - with "more coming online soon."
|
ABBV | Hot Stocks09:28 EST AbbVie CEO 'remains confident' in long-term outlook for the business - Says drug pipeline "remains robust." Says "feels very good" about progress with Skyrizi and Rinvoq. Anticipates achieving "numerous" regulatory milestones in 2022 across pipeline. Comments taken from Q4 earnings conference call.
|
MICT | Hot Stocks09:27 EST MICT, Inc. receives notice of non-compliance from Nasdaq - MICT, Inc. announces its receipt of a Notification Letter from Nasdaq that its stock has been under a minimum bid price of $1.00 for a period of 30 days. The Company has been given 180 calendar days to regain its compliance and achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days. According to the Notification Letter, should the Company not regain compliance by July 26, 2022, an additional 180 days may be granted to regain compliance, so long as the Company meets the Nasdaq Capital Market continued listing requirements and notifies Nasdaq in writing of its intention to cure the deficiency during the second compliance period. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180-day period, then Nasdaq will issue a de-listing determination, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.
|
AVID | Hot Stocks09:24 EST Avid Technology announces AVID NEXIS EDGE - Avidy extended the power of its collaborative post production solutions with the introduction of Avid NEXIS EDGE. The company said, "This innovative new software option enables post production teams to work from any location, delivering secure, remote access to media and metadata. Avid NEXIS EDGE enables team members to access the same proven collaborative workflows relied on by thousands of post production facilities worldwide, without requiring collaborators to be co-located. Avid NEXIS EDGE will be previewed at the HPA Tech Retreat in Rancho Mirage, California, starting on February 21, 2022."
|
F | Hot Stocks09:19 EST Ford reports January U.S. sales flat at 143,531 vehicles - "Ford market share increased over a year ago on strong demand for our newest products such as Bronco, Maverick and Mach-E. Ford took in a record 90,000 new vehicle orders in January. Vehicles are turning at a record pace on dealer lots, as we work to fill these orders. This year represents a turning point for Ford in electrified vehicles, as our electrified portfolio grew at nearly four times the rate of the industry segment, with E-Transit and F-150 Lightning set to hit the market," said Andrew Frick, vice president, Ford Sales U.S. and Canada. Ford brand sales were up 1.4% and the overall industry declined 9.0%, the company said. Overall, Ford and Lincoln total share in January was 13.9% - up 1.3 percentage points from a year ago. Reference Link
|
S | Hot Stocks09:19 EST SentinelOne partners with Noetic Cyber for cybersecurity solutions - SentinelOne announced a partnership with Noetic Cyber, a cloud-based continuous cyber asset management and controls platform. This partnership delivers an end-to-end cybersecurity asset management solution that leverages SentinelOne's endpoint and cloud workload telemetry, combined and correlated with information from other information sources, to generate a multidimensional map of all assets and their cyber relationships. Joint customers install the SentinelOne Connector into the Noetic platform and provide it with API credentials to establish a bi-directional integration between the two platforms. The integration of SentinelOne Singularity XDR and the Noetic platform aims to enable teams to extend the visibility, detection and endpoint insights of SentinelOne into a wider asset inventory and management architecture, maximizing their value.
|
WTER | Hot Stocks09:19 EST Alkaline Water now available at Meijer Express locations across Midwest - Alkaline Water announced that its Alkaline88 1-Gallon and 1-Liter bottles are now available at most of the more than 220 Meijer Express locations across the Midwest.
|
MTTR | Hot Stocks09:17 EST Orangetheory Fitness adopts Matterport Capture Services - Matterport announced that Orangetheory will utilize Matterport Capture Services to scan and create digital twins of all its U.S. studios, ensuring design and layout are consistent with global brand guidelines. With more than 1,250 studios across the U.S., Orangetheory's operational teams will gain significant cost and time savings by enabling highly efficient collaboration, analysis, and decision making using digital twins of its studios remotely.
|
CPTK BRVS | Hot Stocks09:17 EST Crown PropTech Acquisitions merger partner Brivo partners with Sitasys - Brivo (BRVS), a provider of cloud-based access control and smart building technologies that recently entered into a definitive merger agreement with Crown PropTech Acquisitions (CPTK) anticipated to close in Q2, announced a partnership with Sitasys AG, a provider of security technology solutions through its cloud alarm management platform evalink talos, enabling security professionals to centralize critical security and operations management within a single platform. The integration allows security professionals to centralize security and operations management within a single platform. The Brivo integration for evalink talos brings together alarm panels, tracking systems, cameras, and access control into a unified security platform, Brivo Access, which leverages analytics, business intelligence, and machine learning to simplify access control and generate actionable insights from big data.
|
TOPS | Hot Stocks09:16 EST TOP Ships gets credit committee approval of financing for newbuilding vessel - TOP Ships announced that it has obtained credit committee approval from a major international financier for the financing, via a sale and leaseback agreement, of up to 80% of the shipbuilding cost of the Suezmax tanker vessel M/T Eco Oceano CA currently under construction at Hyundai Samho Heavy Industries Co., Ltd. in South Korea. The company had previously announced that it had entered into a non-binding termsheet and disclosed the main terms of the financing while awaiting credit committee approval. The financing is only subject to the agreement and the execution of customary legal documentation following which the Company's remaining newbuilding program will be fully funded.
|
MYSZ | Hot Stocks09:16 EST My Size names Javier Brandwain as Chief Commercial Officer - My Size is pleased to announce the appointment of Javier Brandwain as its first-ever Chief Commercial Officer. Most recently, Brandwain served as Director of Latin America and Caribbean at 7 For All Mankind International.
|
CLRO GOOG | Hot Stocks09:16 EST ClearOne gets Versa Lite CT certification from Google for Google Meet - ClearOne (CLRO) announces Google (GOOG:GOOGL) Meet certification of its Versa Lite CT, a USB audio-enabled Beamforming Ceiling Tile Microphone that brings cost-effective and superb professional conferencing audio to small- and mid-sized spaces enhancing the meeting room, classroom, and work-from-home experience. Google Meet ranks among the top 5 for growth in the cloud meetings and team collaboration market, according to a recent Frost & Sullivan report. With Google Meet certification of ClearOne's Versa Lite CT, users can be confident that they will have an outstanding collaboration experience. The ClearOne COLLABORATE .Versa Lite CT is a professional USB-enabled audio-conferencing microphone system designed to dramatically enhance the audio experience with natural-sounding conversations and highly intelligible speech. It includes a beamforming microphone array with full 360 degrees coverage, full-duplex transmission, AEC Adaptive Steering , and a ceiling-tile form factor and optional adapter for home office ceilings. Also included is the Versa USB Expander. Consumers use a USB cable to connect the Versa USB expander to the USB port of their laptop or room computer for crystal-clear room audio.
|
WKEY | Hot Stocks09:15 EST WISeKey launches NFT service for luxury watches - WISeKey International Holding announced that it has finalized its NFT Marketplace WISe.ART and it is ready now to launch its TrustedNFT.IO service for luxury high-end and vintage watches. The company said, "WISeKey uses a unique patented method to secure the authenticity and provenance of watches through cutting-edge authentication microprocessors combined with identity blockchain technology, which together with on-the-ground measures ensures the authenticity of the watch and generates its correspondent digital twin. WISeKey, was the first company in the world to use dual factor authentication combined with blockchain technology to secure luxury watches, and currently protects over 2.5 million luxury watches. Since 2010, WISeKey has collaborated with manufactures of luxury watches deploying this unique technology to integrate semiconductors tags powered with its VaultIC154 NFC secure element and provide brands with the ability of: issuing a storage device comprising of a digital certificate of authenticity; checking, when required, the validity of the digital certificate of authenticity; modifying, when required, the status of validity of the digital certificate of authenticity."
|
ANSS | Hot Stocks09:11 EST Ansys enters strategic collaboration with AWS for cloud engineering simulations - Ansys announced a strategic collaboration with Amazon Web Services, identifying the CSP as the preferred and recommended partner for Ansys Gateway powered by AWS. The collaboration will enable deployment of Ansys products on AWS. By leveraging connected ecosystem applications in a cloud environment, Ansys customers aim to reduce time to market, reduce costs, and innovate faster. The newly formed collaboration will provide a browser-based, location-independent solution for Ansys customers. With Ansys Gateway powered by AWS customers will be able to access Ansys applications, enabling faster, flexible, and highly-scalable engineering simulations.
|
BRDS | Hot Stocks09:10 EST Bird Global announces pilot program with WeGo Public Transit in Nashville - Bird Global and WeGo Public Transit, Nashville's public transit agency, announced a pilot program in which the two entities will team up to bridge first- and last-mile transit gaps with Bird's eco-friendly micro-electric scooters.
|
KD PSTG | Hot Stocks09:10 EST Kyndryl Holdings, Pure Storage announce global alliance - Kyndryl (KD) and Pure Storage (PSTG) announced a global alliance that joins the expertise and operational experience of Kyndryl with the best-in-class storage technology of Pure to deliver mission-critical capabilities to enterprises. As part of the new alliance, Kyndryl will become a key delivery partner for Pure, expanding on already integrated solutions and increasing its existing Pure skills and capabilities to drive transformative business outcomes for customers. Together, Pure and Kyndryl will deliver jointly optimized solutions to address the complex challenges enterprises face related to application and infrastructure modernization, automation, multicloud management, containerization, and more - providing cyber resiliency elements natively at the storage layer to enable cloud-based applications coupled with data portability in the cloud or on-premises.
|
ROKU | Hot Stocks09:08 EST Roku expands advertising business to Mexico - Roku announced the expansion of the company's advertising business to Mexico, allowing brands and content providers to reach even more consumers through ad-supported content. As part of the launch, Roku has partnered with Entravision, a global digital marketing and media company with local operations in Mexico, to help brands effectively reach consumers by advertising on the Roku streaming platform.
|
RNW | Hot Stocks09:08 EST ReNew Energy Global authorizes $250M share repurchase program - ReNew Energy Global has authorized a new $250M share repurchase program to buy back Class A Ordinary Shares in the capital of the company, which will be funded through cash received from the company's recent sale of its 117 MW/138 MWp solar rooftop portfolio, which was at an EV/run rate adjusted EBITDA multiple of approximately 9.5x, as well as from its current cash balance. The company is currently evaluating further offers to sell minority interests of assets at similar indicated valuation multiples. The company will only commence the buyback under the Share Repurchase Program following approval by the court of the cancellation of the company's share premium and registration of such order with the Companies House as required under the UK Companies Act, 2006 and creation of distributable profits for the company to undertake any share repurchases under the Share Repurchase Program. It is expected that all approvals will be received and repurchases could commence in mid-February 2022.
|
XBIT JNJ | Hot Stocks09:08 EST XBiotech executes manufacturing agreement with Janssen - XBiotech (XBIT) announced that it executed Manufacturing Agreement with Janssen (JNJ) Research & Development to manufacture clinical product, including Bermekimab, a True Human monoclonal antibody sold to Janssen by XBiotech in December 2019. The new agreement will extend XBiotech's manufacturing support until December, 2023. John Simard, XBiotech's Chairman and CEO, stated, "We are pleased to be able to continue to support Janssen in its development of bermekimab. While contract manufacturing is not a core business, manufacturing bermekimab fits well into our system and revenue generated extends our runway for the development of our up and coming therapeutics."
|
TENB | Hot Stocks09:07 EST Tenable Holdings expands Tenable.cs capabilities - Tenable announced new capabilities for Tenable.cs, its cloud-native application security platform. Tenable.cs delivers full lifecycle cloud-native security to address cyber risks from build to runtime. With the new features, organizations can secure cloud resources, container images and cloud assets to provide end-to-end security from code to cloud to workload. Tenable.cs enables organizations to programmatically detect and fix cloud infrastructure misconfigurations in the design, build and runtime phases of the Software Development Lifecycle (SDLC) to prevent unresolved insecure configuration or exploitable vulnerabilities from reaching production. Tenable.cs secures infrastructure as code before deployment, maintains a secure posture in runtime, and controls drift by synchronizing configuration between runtime and IaC. The IaC remains the single source of truth, eliminating the need for complex and manual processes. The solution also includes Frictionless Assessment and Nessus Vulnerability Assessment for cloud workloads as well as Container Security to assess cloud hosts and container images for vulnerabilities without the need to manage scan schedules, credentials or agents.
|
BL... | Hot Stocks09:07 EST BlackLine expands partnership with Google Cloud - Building on its investment in the Google (GOOG, GOOGL) Cloud Platform two years ago, BlackLine (BL) announced it is joining forces with Google Cloud once again to bring enhanced automation solutions for finance and accounting to organizations around the world. Under the terms of a new agreement, the two companies will collaborate on joint selling and go-to-market activities to further help companies on their digital finance transformation and modern accounting journeys.
|
IDFB | Hot Stocks09:07 EST BAWAG Group agrees to acquire Peak Bancorp for $12.05 per share - Peak Bancorp, the holding company for Idaho First Bank, announced the signing of an agreement to sell 100% of the shares of Peak Bancorp, Inc. to BAWAG Group, a publicly listed holding company headquartered in Vienna, Austria for $65M. The transaction represents a diluted per share price of $12.05, and is subject to shareholder and regulatory approval. "BAWAG Group will work with the current leadership team of Idaho First Bank to continue growing its community banking focused business in Idaho and adjacent markets, while also providing the operational support and financial strength of a broader banking group. The acquisition enables BAWAG Group to expand its footprint in the United States and better position it for future growth in one of the bank's core markets," the company stated. Todd Cooper, CEO and President of Peak Bancorp, Inc., stated, "We are extremely excited about the opportunity to join BAWAG Group, and are proud to be a focal point for its U.S. expansion efforts. This partnership will allow us to continue serving our markets with a Community First focus. We will be able to leverage BAWAG's resources, depth, and diversification to better serve our communities and banking customers, while also providing exceptional value to Peak Bancorp shareholders."
|
NVCN | Hot Stocks09:06 EST Neovasc announces dismissal of securities class action complaint - Neovasc announced the complete dismissal of the consolidated amended complaint in the shareholder class action case captioned In re Neovasc Inc. Securities Litigation, Case No. 7:20-cv-09313, filed in the United States District Court for the Southern District of New York. The consolidated amended complaint was dismissed in its entirety with prejudice and without leave to amend. "From the beginning, we committed to vigorously defend against these allegations," said Fred Colen, CEO of Neovasc. "We could not be more pleased with the Court's decision to completely dismiss this action with prejudice, which is a clear rejection of the claims advanced in this litigation. We intend to continue to focus on our important mission of creating better outcomes for difficult-to-treat cardiology patients as we move forward."
|
MIGI | Hot Stocks09:06 EST Mawson Infrastructure, Voltus team to deliver 100 MW virtual power plant to PJM - Voltus and Mawson Infrastructure Group announce plans to deliver 100 megawatts of distributed energy resources to the PJM electricity grid in 2022. Mawson is building a new 100 MW cryptomining facility on the grounds of a former industrial site in Midland, Pennsylvania with the intention of bringing 50 MWs of load online by March 2022 and an additional 50 MWs by June 2022. This capacity is expected to be available to PJM's grid operators as a grid balancing resource 24/7/365 through the Voltus DER marketplace software platform. "Mawson actively works to reduce energy consumption and limit our environmental impact as we build energy-efficient next-generation digital infrastructure," explains Mawson Chief Operating Officer Liam Wilson. "Incorporating the best practice of distributed energy resource program participation through the Voltus software platform into our Midland development plans was another opportunity for Mawson to be a steward of the community and electricity grid that is serving us." "Cryptomining load is expected to reach nearly 10,000 MWs in the US over the next five years," explains Gregg Dixon, Voltus CEO and Co-founder. "Voltus can control these loads in a fully automated fashion, connecting this capacity to power markets that value them, resulting in cash back to miners, reliable resources for grid operators, and a balancing resource to improve the reliability of much-needed renewable energy. Digital infrastructure leaders like Mawson recognize that partnering with Voltus supports the grid and provides a competitive advantage in the power-cost driven world of cryptomining."
|
SNCR | Hot Stocks09:05 EST Synchronoss reports accelerated cloud subscriber growth in Q4 - Synchronoss Technologies reported an 18% year-over-year increase in subscribers within its Synchronoss Cloud business for the fourth quarter of 2021. The 18% increase represents an acceleration from 16% growth in the prior quarter and 15% growth in the same period in 2020. The key drivers behind the Company's continued cloud subscriber growth include further adoption by existing customers as well as the signing of new Synchronoss Cloud customers. In 2021, Synchronoss secured cloud contracts with four new customers. "The strength of our cloud subscriber performance in Q4 2021 reflects our commitment to Synchronoss Cloud as the future growth driver of our business," said Jeff Miller, President and CEO of Synchronoss. "We are continuing to place greater focus on this strategic platform, delivering new offerings, feature enhancements, and user experiences to support our global expansion. We entered the new year with strong operating momentum giving us confidence in our ability to deliver healthy, double-digit subscriber growth in 2022, which should translate to greater topline expansion over time as new customers launch and existing customers ramp their cloud offerings."
|
BWAGF | Hot Stocks09:05 EST BAWAG Group to acquire Peak Bancorp for $65M - Peak Bancorp announced the signing of an agreement to sell 100% of the shares of Peak Bancorp, Inc. to BAWAG Group, a publicly listed holding company headquartered in Vienna, Austria for $65M. The transaction represents a diluted per share price of $12.05, and is subject to shareholder and regulatory approval. BAWAG Group will work with the current leadership team of Idaho First Bank to continue growing its community banking focused business in Idaho and adjacent markets, while also providing the operational support and financial strength of a broader banking group. The acquisition enables BAWAG Group to expand its footprint in the United States and better position it for future growth in one of the bank's core markets.
|
BCOV | Hot Stocks09:05 EST Brightcove acquires Wicket Labs, terms undisclosed - Brightcove announced it has acquired Wicket Labs, an audience insights company that gives users visibility into content and subscriber analytics. Brightcove's intelligent video platform enables customers to deliver broadcast-quality video to viewers around the world and measure its effectiveness with real-time analytics, including video and viewer insights. Wicket Labs' co-founders and all of its employees will join the Brightcove product and engineering organization.
|
NVEI | Hot Stocks09:03 EST Nuvei has gone live as payment provider with THG - Nuvei announces that it has gone live as a payment provider with THG, the global technology platform company specialising in taking brands direct to consumers. THG is utilizing Nuvei's recurring billing service that allows secure, automated re-purchasing via tokenization. "We're delighted to partner with THG," said Philip Fayer, Chair and CEO of Nuvei. "With a shared ethos of exceptional experience, innovation and service, we're empowering online brands to operate in more countries and accept more forms of regionally familiar and preferred digital payment methods to drive conversion."
|
ENVI GRNA | Hot Stocks09:01 EST Environmental Impact Acquisition's business combination with Greenlight approved - Environmental Impact Acquisition's (ENVI) business combination with Greenlight Biosciences was approved in a shareholder vote held yesterday, with 80.7% of shareholders participating in the vote and 78.6% voting in favor of the combination. Environmental Impact Acquisition anticipates changing its name to GreenLight Biosciences (GRNA) public-benefit corporation. Environmental Impact Acquisition anticipates closing the business combination on February 2nd. In connection with the closing, the company will change its name to GreenLight Biosciences Holdings, and the combined company's shares of Class A common stock and public warrants are expected to trade on the Nasdaq exchange beginning on February 3, 2022, under the ticker symbols "GRNA" and "GRNA.WS," respectively.
|
DMAC | Hot Stocks09:00 EST DiaMedica Therapeutics appoints Dominic Cundari as chief commercial officer - DiaMedica Therapeutics announced the appointment of Dominic Cundari as chief commercial officer. In this role, Cundari will be focused primarily on the commercial planning, positioning and launch preparations for DM199 in acute ischemic stroke. Prior to joining DiaMedica, Cundari spent over twenty years launching innovative products and building and managing commercial organizations in multiple therapeutic areas at Genentech.
|
FTK | Hot Stocks08:46 EST Flotek signs long-term chemistry solutions agreement with ProFrac - Flotek has entered into a long-term agreement with ProFrac, a private North American provider of hydraulic fracturing services, to provide its full portfolio of sustainable chemistry solutions to a dedicated portion of ProFrac's hydraulic fracturing fleets. Flotek will provide full downhole chemistry solutions for a required minimum number of fleets for three years. This creates an immediate expected contracted backlog of revenue greater than $230M, based on estimated chemical volumes and pricing, and is anticipated to represent annual recurring revenue. n exchange for entry into the multi-year revenue commitment, ProFrac will receive $10M initial principal amount of notes that are convertible into Flotek common stock. In addition, ProFrac will be permitted to designate up to two new directors to Flotek's board of directors.
|
DHI | Hot Stocks08:42 EST D.R. Horton sees Q2 home sales gross margin similar to, slightly better than Q1
|
DHI | Hot Stocks08:42 EST D.R. Horton sees number of net sales orders in Q2 equal to 2Q21
|
APWC | Hot Stocks08:42 EST Asia Pacific Wire & Cable Corp completes rights offering - Asia Pacific Wire & Cable Corporation announced the completion of its rights offering. The subscription period for the rights offering expired at 5:00 p.m. Eastern Standard Time on January 31, 2022, the expiration date for the rights offering. In the rights offering, which was oversubscribed, the Company issued and sold an aggregate of 6,796,558 common shares pursuant to the exercise of subscription rights, raising gross proceeds of approximately $8.3M before any expenses of the rights offering. Following the completion of the rights offering, the Company had 20,616,227 common shares outstanding. The net proceeds of the rights offering will be used for general working capital and corporate purposes. The subscription price in the rights offering was $1.22 per common share. In accordance with the terms of the rights offering, this subscription price is equal to 90% of the lower of the volume weighted average price per common share on the Nasdaq Capital Market over the five consecutive trading days through and including the expiration date of the rights offering, and the closing price per common share on the Nasdaq Capital Market on the expiration date of the rights offering
|
CETX | Hot Stocks08:41 EST Cemtrex announces $0.5M follow-on investment into Masterpiece Studio - Cemtrex announced a second investment of $0.5M into Masterpiece Studio, a developer of a professional desktop and VR application suite that offers 3D content creation tools, primarily for virtual reality and the Metaverse.
|
GNSS | Hot Stocks08:40 EST Genasys announces multiple communications software services contracts in Texas - Genasys announced multi-year Genasys Emergency Management, GEM, software services contracts with the State of Texas Office of the Attorney General, Texas OAG, Madison County, and the Town of Little Elm. The Company's GEM contract with the Texas OAG was renewed and new GEM contracts replaced competitors' emergency notification services in Madison County and Little Elm. "The Texas OAG utilizes GEM's Desktop Panic to help ensure the safety of case workers during child support and protective services duties," said Richard Danforth, Chief Executive Officer, Genasys. "Our GEM contract with Madison County includes Genasys' weather warning module, which quickly gathers data on approaching storms and alerts residents in the path of severe weather to take appropriate life safety actions. The additional GEM software services include visitor management and sending alerts and emergency notifications to port workers and visitors via SMS, mobile phones, and email."
|
DHI | Hot Stocks08:40 EST D.R. Horton: Jan. home starts, net sales order volume in line with expectations
|
JSDA WSNAF | Hot Stocks08:40 EST Jones Soda, Wesana Health, Mike Tyson partner to launch nootropic supplement - Jones Soda Co. (JSDA), Wesana Health (WSNAF) and professional boxer and celebrity Mike Tyson announced their partnership to bring a completely new functional supplement experience to market. The company said, "Inspired by Mike Tyson's personal journey in pursuit of optimal mental health through the use of natural, fungi and plant-based solutions, Jones worked closely with Wesana's science team to create a distinct line of liquid supplements designed to promote focus, clarity and support brain health." Launching in the first quarter of 2022, Jones Nootropics will initially be available in two flavors. The flavors, Tyson's Punch and Tiger's Blood, both feature fruity, crisp, and flavor-forward taste profiles that are great complements to the functional nootropic experience. The initial run will be available for purchase on www.jonessoda.com.
|
GLP | Hot Stocks08:39 EST Global Partners announced the purchase of Miller's Neighborhood Market - Global Partners announced the purchase of Miller's Neighborhood Market, expanding the Partnership's retail footprint in the mid-Atlantic region. The purchase price was not disclosed. The acquisition includes 23 convenience stores and fuel supply agreements with 34 locations primarily in Virginia. "The addition of Miller's significantly expands our retail presence in the mid-Atlantic region and complements our portfolio of over 80 controlled sites and dealer network. Acquiring these high-quality locations enables us to further capitalize on our scale, supply relationships, and our integrated model to enhance product margin along each step of the value chain," said Global Partners LP President and CEO Eric Slifka. "Like Global, Miller's is a family-founded business with shared values around community and a commitment to customer experience. This purchase demonstrates our appetite to grow our book of business." Global delivers essential fuel, food and supplies to local communities and supports non-profits and community organizations throughout its footprint, at more than 1,600 retail locations and more than 20 bulk energy terminals.
|
EVOK | Hot Stocks08:38 EST Evoke Pharma, EVERSANA extend commercialization partnership for Gimoti - Evoke Pharma and EVERSANA Life Science Services announced the extension of their agreement to continue collaborating on the commercialization and distribution of Gimoti nasal spray in the United States through the end of 2026. This amendment increases the percentage of net product profit retained by Evoke and accelerates the reimbursement of commercialization costs to Eversana after the product breaks even on a monthly basis. The initial term provided in the original agreement was five years following FDA approval, June 19, 2025, but this amendment will extend the term of the agreement through December 31, 2026. "We continue to see expanding enrollments and filled prescriptions for the brand and believe in the long-term opportunity for Gimoti. We are excited to continue leveraging the expertise of EVERSANA's team for our sales and distribution efforts, given their large-scale commercialization capabilities for products generated by life science companies," commented Dave Gonyer, CEO of Evoke Pharma.
|
QTNT | Hot Stocks08:37 EST Quotient announces equity awards - Quotient announced the scheduled grant of equity awards to Mr. Esteban Uriarte, who has been appointed as the Chief Manufacturing Operations Officer of the Company effective February 1, 2022. In connection with his appointment, the Company granted Mr. Uriarte 173,994 performance-based restricted share units, 104,396 Restricted Share Units and share options to purchase 106,983 of the Company's ordinary shares. Such grants were issued outside of the Company's 2014 Stock Incentive Plan and were approved by the Company's Board of Directors and the Remuneration Committee of the Board of Directors pursuant to the inducement grant exception under the Nasdaq Rule 563(c)(4), as an inducement that is material to Mr. Uriarte joining the Company as the Chief Manufacturing Operations Officer. The Sign-On PSUs will vest on the third anniversary of the grant date, provided specific performance criteria have been met. These performance criteria include the Company achieving certain financial targets. The Sign-On RSUs will vest in three equal instalments on each of the first, second and third anniversaries of the grant date. The Sign-On Options will also vest in three equal instalments on each of the first, second and third anniversaries of the grant date. The vesting of the awards will be subject to Mr. Uriarte continued service with the Company on each applicable vesting date.
|
DHI | Hot Stocks08:36 EST D.R. Horton 'well-positioned' to deliver double digit volume growth in FY22
|
CODI | Hot Stocks08:36 EST Altor Solutions acquires Foam Concepts, terms not disclosed - Altor Solutions, a subsidiary of Compass Diversified, announced that it has acquired Foam Concepts, Inc. . Financial terms of the transaction were not disclosed. Altor's acquisition of Foam Concepts strengthens its position as a leading provider of packaging and componentry solutions. Founded in 1986 and headquartered in Uxbridge, Massachusetts, Foam Concepts is a manufacturer of expanded polystyrene foam products for the cold chain, protective packaging and construction end-markets. With the addition of Foam Concepts and its facility, Altor will operate 19 manufacturing facilities across the United States to help customers solve their Packaging, Insulation and Componentry needs.
|
SOLO | Hot Stocks08:36 EST ElectraMeccanica to begin delivery of SOLO Cargo EV to fleet, customers in Q2 - ElectraMeccanica Vehicles announced the specifications of its SOLO Cargo EV as well as the timeline for the commencement of deliveries, expected to begin in the second quarter of 2022. The SOLO Cargo EV has a range of 100 miles and a top speed of 80 mph, making it safe for highway use. It also features front and rear crumple zones, side impact protection, a Kevlar reinforced safety hoop, torque-limiting control as well as power steering, power brakes, air conditioning and a configurable entertainment system. SOLO Cargo EV dimensionshave been expanded to include cargo space for a total of 11.8 cubic feet of storage space - as compared to 5 cubic feet of storage in the standard SOLO EV. The vehicle is 53" tall and approximately 123" long, and the rear cargo dimensions are 37.5" long x 34" wide x 16" high. The Cargo version contains a variety of features for commercial applications.
|
IFBD | Hot Stocks08:36 EST Infobird signs contract with Nippi Japan for digital marketing solutions - Infobird has signed a cooperation agreement with Nippi Shanghai, a subsidiary of Nippi Japan, to apply digital marketing solutions to help Nippi Shanghai increase its sales and grow its market share as a supplier of collagen raw materials to the Chinese market. Infobird's comprehensive digital marketing solutions will empower Nippi Shanghai with multi-channel and intelligent marketing system. In the future, Infobird expects to deepen its cooperation with Nippi Shanghai, and continuously expand the application of its digital solutions in the health and wellness industry.
|
DHI | Hot Stocks08:36 EST D.R. Horton still sees significant challenges in supply chain - Comments taken from Q1 earnings conference call.
|
CRSP | Hot Stocks08:34 EST Crispr, ViaCyte announce first patient dosed in Phase 1 trial of VCTX210 - CRISPR Therapeutics and ViaCyte announced the first patient has been dosed in the Phase 1 clinical trial of VCTX210 for the treatment of type 1 diabetes. VCTX210 is an investigational, allogeneic, gene-edited, stem cell-derived product developed in collaboration by applying CRISPR Therapeutics' gene-editing technology to ViaCyte's proprietary stem cell capabilities for the generation of pancreatic cells designed to evade recognition by the immune system. This immune-evasive cell replacement therapy is designed to enable patients to produce their own insulin. The Phase 1 clinical trial of VCTX210 will assess its safety, tolerability, and immune evasion in patients with T1D.
|
YTEN | Hot Stocks08:34 EST Yield10 Bioscience receives favorable CONABIA ruling for camelina lines - Yield10 Bioscience announced it has received a favorable determination from the Argentine Biosafety Commission for three CRISPR genome edited Camelina lines. CONABIA conducted an evaluation of three CRISPR genome edited Camelina lines presented by Yield10 and determined that these plants are similar to conventionally bred Camelina varieties, and thus are not regulated under the biotechnology resolution No. 763/11 of the Ministry of Agriculture, Livestock and Fisheries in Argentina. CONABIA confirmed that because Yield10's edited Camelina does not contain any foreign inserted DNA, this variety can be marketed like conventionally bred Camelina which does not require any pre-market authorizations. The Company's CRISPR edited Camelina lines covered by the CONABIA ruling are E3902 as well as two distinct C3007 Camelina lines developed by Yield10. Yield10 developed line E3902 and the two C3007 Camelina lines as part of its program to identify gene targets useful for increasing oil content in oilseed crops. Yield10 researchers produced line E3902 using CRISPR genome editing to modify three genes involved in oil biosynthesis and oil turnover in Camelina. In field trials to date, the E3902 Camelina line has shown a consistent 5 percent increase in seed oil content as a percentage of seed weight over control plants. The E3902 trait represents a leading trait in Yield10's pipeline and is currently being scaled up to produce oil for sampling. The C3007 trait is at the field testing stage in Camelina and canola to evaluate its activity as a way to increase oil biosynthesis in oilseed crops. Yield10 previously cleared these Camelina lines from regulation in the U.S. under the "Am I regulated?" process administered by the U.S. Department of Agriculture Animal and Plant Health Inspection Service.
|
GRIL | Hot Stocks08:33 EST Muscle Maker's Pokemoto division expands into Florida market - Muscle Maker newest subsidiary Pokemoto, announced it has signed three new franchise agreements in southwest Florida. These three new agreements bring the total of new franchise and development agreements signed to 30 since November 2021. In this same timeframe, Muscle Maker also signed a 40-unit Muscle Maker Grill restaurant development agreement in Saudi Arabia fueling the company's international pipeline. The three new southwest Florida franchise agreements are focused on the Gulf Coast specifically in Lee and Collier counties. "We've had the Florida market on our radar since acquiring the brand in May, 2021 and now our plans to enter the market are coming to fruition... The three newly signed franchise agreements and new corporate locations will bring our total store count to 52, quadrupling our footprint. We are proud of this growth from the Pokemoto brand considering we purchased the company with 13 locations eight months ago. We also inked the Muscle Maker Grill 40-unit restaurant development deal in Saudi Arabia in the same timeframe," said Mike Roper, CEO of Muscle Maker.
|
NNDM | Hot Stocks08:33 EST Nano Dimension's Global Inkjet Systems to present at InPrint Munich - Nano Dimension announced its Global Inkjet Systems Division will present its latest print application capabilities at InPrint Munich, March 15-17, 2022. Developed to meet the ever-increasing market demands of graphics and non-graphics markets, the company's range of products offers original equipment manufacturers and system builders the ability to meet the requirements of high-end, demanding industrial applications. During the show, senior members of the GIS team will be available at Stand A4 2664 to discuss the latest print quality optimization software solutions, ink delivery system components, and printhead control capabilities.
|
BLDP | Hot Stocks08:32 EST Ballard Power delivers two FCwave modules to Norwegian boat operator - Ballard Power has delivered two 200 kW FCwave modules to Norled, one of Norway's largest ferry and express boat operators. The fuel cell modules will power the world's first liquid hydrogen-powered ferry, the MF Hydra, later this year. MF Hydra will be the first hydrogen-powered ship to be approved by the Norwegian Maritime Directorate, the Norwegian Directorate for Civil Protection and Emergency Planning and DNV. The FCwave modules for Norled A/S have been designed, manufactured, and tested at Ballard's Marine Center of Excellence in Hobro, Denmark. The two FCwave marine fuel cell modules have been approved by the DNV classification and certification body.
|
STAR CG | Hot Stocks08:33 EST iStar to sell net lease asset portfolio to Carlyle affiliate for $3.07B - iStar (STAR) announced that it has signed a definitive agreement to sell a portfolio of its owned and managed net lease assets for a gross purchase price of $3.07B. The portfolio consists of 18.3M square feet of institutional quality office, entertainment, and industrial properties located throughout the country. The portfolio is being acquired by an affiliate of Carlyle's (CG) Global Credit platform. The transaction is expected to close in the first quarter, subject to customary closing conditions. The company estimates that it will recognize total net positive impacts to both net income and common equity of approximately $525M and to adjusted common equity of approximately $250M. After repayment of all associated mortgage debt and full repayment of its secured term loan, the company estimates that it will receive net cash proceeds of approximately $1.1B. These estimates are subject to increase or decrease based upon the final purchase price allocations, customary prorations and the exact closing date, and are net of estimated distributions to its venture partner, debt prepayment fees, closing costs, promote fees, and distributions under iStar's long-term incentive plan, iPIP. The company expects to record approximately $40M of net expenses in the fourth quarter of 2021 associated with the transaction, and approximately $565M of net gains in the quarter in which the transaction is completed, currently expected to be in the first quarter of 2022.
|
HPQ | Hot Stocks08:26 EST HP Inc. acquires Choose Packaging, terms not disclosed - HP Inc. announced the acquisition of Choose Packaging, a packaging development company and inventor of the only commercially available zero-plastic paper bottle in the world. Choose's patented technology provides an alternative to plastic bottles and can hold a wide variety of liquid products. Its novel, paper-based bottles are made with naturally occurring and non-toxic materials and pave the way for a new standard for bottling solutions globally. With the integration of Choose into its Personalization & 3D Printing business, HP will focus on scaling its technology and customer footprint to expand the addressable market. There are more than 150 million tons of single-use plastics produced each year and HP intends to disrupt this market with fiber-based, 100% plastic-free packaging. Financial terms of the transaction were not disclosed.
|
BNGO | Hot Stocks08:17 EST Bionano Genomics announces adoption of Saphyr system in two GLH in UK NHS - Bionano Genomics announced the adoption of its Saphyr system by two genetics laboratory hubs, GLH, within the United Kingdom's, UK, National Health Service, NHS. The Newcastle upon Tyne Hospitals NHS Foundation Trust and the Birmingham Women's and Children NHS Foundation Trust intends to utilize the system to evaluate OGM against traditional cytogenetic methods. "With these two new Saphyr placements in the UK's NHS, we continue to broaden our footprint and provide scientists and clinical researchers with the ability to develop a comprehensive, reliable and cost-effective solution for detecting chromosomal abnormalities in hematologic malignancies, genetic conditions and cancer research applications," commented Erik Holmlin, PhD, President and Chief Executive Officer of Bionano. "We welcome these genomic laboratory hubs to the OGM community and look forward to working with them as we strive to transform the way the world sees the genome."
|
SLGC | Hot Stocks08:15 EST SomaLogic announces it will begin assaying 15,000 samples from MESA study - SomaLogic announced that the company will begin assaying samples from the Multi-Ethnic Study of Atherosclerosis, MESA, study beginning in the first quarter of 2022. SomaLogic will use its assay to analyze 105 million protein measurements from 15,000 samples spanning 15 years of clinical interactions. "The MESA study is groundbreaking and we expect it to generate the largest proteomic dataset of an ethnically diverse population," said SomaLogic Chief Executive Officer Roy Smythe, M.D. "This agreement represents yet another demonstration of SomaLogic's support of the data-sharing and data-access policies of the National Institutes of Health that nurture the research enterprise. We hope that sharing this data will expedite its translation into knowledge, products and procedures that make a positive impact on human health." The MESA study is focused on subclinical cardiovascular disease and the risk factors that predict progression to clinical signs and symptoms.
|
FCEL | Hot Stocks08:15 EST FuelCell releases first sustainability report - FuelCell Energy announced the availability of its first sustainability report. The FuelCell Energy 2021 Sustainability Report reaffirms the Company's commitment to team members, community, environmental safety, and a diverse Board of Directors and global team. The report also illuminates how FuelCell Energy is advancing both the Company's and customer's environmental and sustainability agendas. This report introduces a commitment to achieving Net Zero emissions by 2030 on Scope 1 and Scope 2 emissions, and details the efforts and initiatives being undertaken to hit metrics and achieve milestones toward Net Zero 2030. Also highlighted are the advancements in developing technologies and processes by which FuelCell Energy plans to efficiently decarbonize inefficient power sources and produce clean, storable hydrogen. FuelCell Energy's report aligns with both the Sustainability Accounting Standards Board and the Task Force on Climate-Related Financial Disclosures reporting criteria. Highlights from the Sustainability Report include: The link between how FuelCell Energy fulfills its corporate purpose and how the Company helps customers achieve their own sustainability goals; How FuelCell Energy's commitment to sustainability fully extends into its operations and the management of related resources that support the execution of the sustainability plan; How FuelCell Energy's unique hydrogen and carbon capture solutions are being developed to support accelerating the greening of the electric grid; Diverse use cases with partners such as Toyota, ExxonMobil Research and Engineering, Pfizer, wastewater districts, and local municipalities; Data and key performance indicators on topics that are material to the Company's global stakeholders.
|
EAST | Hot Stocks08:14 EST Eastside Distilling CEO Paul Block resigns, Geoffrey Gwin named interim CEO - Eastside Distilling announced that Paul Block, the CEO and Chairman of the Board, resigned from his positions with the company on February 1st. The company has named Geoffrey Gwin as the interim CEO, and Elizabeth Levy-Navarro as the Chairman of the Board. In addition, the company announced the appointment of Amy Lancer to the position of Chief Commercial Officer of Spirits.
|
SBEV | Hot Stocks08:13 EST Splash Beverage signs TapouT distribution deal with Tri County Beverage - Splash Beverage Group, announced that it has signed a distribution agreement with Tri County Beverage in Michigan to distribute TapouT through suburbs of Detroit. Tri County Beverage, headquartered in Warren, Michigan was created in 1994 though it can trace its roots back to 1958. The company today services Oakland and Macomb Counties with annual sales of 3 million cases.
|
ABVC | Hot Stocks08:13 EST ABVC BioPharma announces investigator meeting for Phase II Part 2 ADHD study - ABVC Biopharma announced that the Principal Investigator Meeting for the ABV-1505 Phase II Part 2 ADHD clinical study will be held on February 14, 2022. Principal investigators will virtually participate in the meeting to discuss potential further improvement to the study protocol prior to initiation. This randomized, double-blind, placebo-controlled Part 2 study involves a total of approximately 100 patients from the United States and Taiwan. The Part 2 study is targeted to begin in the first quarter of 2022 and expected to be completed at the end of 2022. "We expect to have a productive discussion finalizing the Part 2 study protocol on February 14th," said Dr. Howard Doong, Chief Executive Officer of ABVC BioPharma. "Site initiation visits will quickly follow the meeting to initiate the study at all participating sites." Further, Dr. Doong emphasized the importance of ABVC BioPharma's focus on botanical sourcing in drug development. "Our clinical trials continue to demonstrate the significant therapeutic benefits of our plant-based medicines with few - if any - side effects in treating certain serious medical conditions."
|
PBI | Hot Stocks08:12 EST Pitney Bowes sees FY22 revenue, EBIT growth in low-mid single digits - In its Q4 earnings press release, Pitney Bowes stated: "The company expects annual revenue and EBIT to grow over prior year in the low-to-mid single digit range. The company expects to refine expectations throughout the year, especially as Covid and supply chain issues dissipate."
|
UBX | Hot Stocks08:12 EST Unity Biotechnology reports granting of employment inducement awards - UNITY Biotechnology announced that from January 18, 2022, through February 1, 2022, the Compensation Committee of the Board of Directors granted a new employee a stock-based award covering an aggregate of 2,750 shares of UNITY common stock, including options to purchase an aggregate of 2,750 shares of UNITY common stock. The stock-based award was granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule 5635(c)(4).
|
UGRO | Hot Stocks08:11 EST Urban-Gro announces additional $1.5M expansion of stock repurchase program - urban-gro announced that its Board of Directors has authorized an additional $1.5M expansion to the Company's existing stock repurchase program. This expansion builds upon the Company's existing repurchase authorization of $7M, which was recently increased by $2M on January 18, 2022. Under the new authorization, the Company may now purchase up to a combined $8.5M of the Company's common stock from time to time in the open market or in privately negotiated transactions in compliance with the applicable rules and regulations of the Securities and Exchange Commission.
|
DXR | Hot Stocks08:11 EST Daxor commences trading on Nasdaq Capital Market - Daxor Corporation announces it commenced trading on the NASDAQ Capital Markets as of today, February 2, 2022 and will visit the Nasdaq MarketSite in Times Square on Friday, February 4, 2022. In honor of the occasion, Michael Feldschuh, CEO & President will ring the Opening Bell.
|
TRIN... | Hot Stocks08:10 EST Recovery Engineering to receive $59.8M in proceeds from equity investment sales - Trinity Capital (TRIN) will receive approximately $59.8M in aggregate net proceeds from the sale of its equity investments in Lucid (LCID) and Matterport (MTTR). In January 2022, Trinity disposed of 1,867,973 shares of common stock in Lucid and 571,941 shares of common stock in Matterport, which represented a combined investment at a cost of approximately $9.0M. As a result, the company expects to recognize an aggregate net realized gain of approximately $50.8M in the quarter ended March 31, 2022 from the sale of its equity investments in Lucid and Matterport.
|
COMM | Hot Stocks08:10 EST CommScope enters collaboration with Meta Connectivity - CommScope announced a collaboration with Meta Connectivity to join its Evenstar program and accelerate the adoption of Open RAN by developing open reference designs. As the demand for internet connectivity expands at a rapid pace, the infrastructure that supports it needs to grow and improve. To address this requirement, CommScope will work with Meta Connectivity, alongside a network of industry ecosystem companies in the Evenstar program with the intent to design and build flexible, efficient RAN components. The collaboration will focus on developing a Massive MIMO reference design based on O-RAN Alliance interoperability specifications.
|
GROM | Hot Stocks08:10 EST Grom Social's Top Draw Animation adds $950k in production assignments - Grom Social Enterprises announced its wholly-owned subsidiary, Top-Draw Animation, has executed an agreement with an international programming supplier that will generate an additional $950,000 in business. The work, announced today by Top Draw's President, Russell Hicks, will further bolster animation production to TDA's bustling studio in Manila, the Philippines, where it produces animated series, movies, specials and short-form content on behalf of major international programming suppliers, studios and network
|
BRTX | Hot Stocks08:10 EST BioRestorative announces notice of allowance for patent application in Japan - BioRestorative Therapies announced that the Japanese Patent Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem Program. The notice of allowance was issued on January 26, 2022 and is related to a new patent application not previously announced. "We continue to see success developing a comprehensive global patent portfolio for ThermoStem and this latest notice of allowance further strengthens our overall IP position in using scaffolds as a delivery system." said Lance Alstodt, the Company's CEO "The claims of this application are the result of BioRestorative's expertise in applying cell therapy to treat metabolic disorders. They underscore the potential value of ThermoStem as a novel treatment for diseases such as diabetes and obesity, which represent major unmet needs."
|
SDC | Hot Stocks08:09 EST SmileDirectClub expands oral care product offerings with Stain Barrier - SmileDirectClub announced the expansion of its oral care product offerings with its new Stain Barrier. The company said, "The latest whitening innovation from SmileDirectClub, Stain Barrier protects teeth with an invisible shield against common staining beverages including coffee, tea, red wine and soda. The easy-to-use gel applicator utilizes a gentle whitening agent to block stains for up to 4 hours and is safe for daily use. Complete with 30 applications per pen, Stain Barrier is designed to be used 10 minutes before consuming beverages and dries clear within 5-10 seconds, leaving behind a cool mint flavor. Thanks to its ease and portability, Stain Barrier is the perfect product to use at home or on the go." The SmileDirectClub Stain Barrier is now available at Shop.SmileDirectClub.com and on Amazon.com and will start hitting over 4,000 Walmart shelves in mid-February. The new Stain Barrier complements SmileDirectClub's existing oral care product offerings, including the recently released Dissolvable Strips and Pro Whitening System Plus
|
PDSB MRK | Hot Stocks08:08 EST PDS announces preliminary efficacy achievement in VERSATILE-002 Phase 2 trial - PDS Biotechnology (PDSB) announced its VERSATILE-002 Phase 2 study for the treatment of advanced human papillomavirus-associated head and neck cancer achieved its preliminary objective response benchmarks. The trial, which studies PDS0101 in combination with Merck's anti-PD-1 therapy KEYTRUDA, will now progress to full enrollment of 54 patients in this group of checkpoint inhibitor naive patients. As pre-specified in the clinical trial design, the achievement of an objective response as measured by radiographic tumor responses according to RECIST 1.1 confirmed by two separate measurements among at least four or more of the first 17 patients in the CPI naive arm allows that arm to progress to full enrollment. VERSATILE-002, being conducted in collaboration with Merck (MRK). "The achievement of this important milestone in the VERSATILE-002 Phase 2 clinical trial strengthens the evidence of our novel Versamune platform's potential ability to induce high levels of tumor-specific CD8+ killer T-cells that attack the cancer to achieve tumor regression," commented Dr. Lauren Wood, Chief Medical Officer of PDS Biotech. "The initial data solidifies our belief that PDS0101's demonstrated preclinical efficacy when combined with KEYTRUDA has the potential to significantly improve clinical outcomes for patients with advanced HPV16-positive head and neck cancers."
|
IDEX | Hot Stocks08:07 EST Ideanomics subsidiary receives order for 19 electric vehicles from AVTA - Ideanomics' wholly-owned subsidiary US Hybrid announced an order from Antelope Valley Transit Authority - AVTA - for 19 battery-electric, long-range, ADA-compliant transit vans. The vans to be delivered will undergo durability and safety testing at the Altoona test track, as required by the Federal Transit Administration to be eligible for federal funding. The battery-electric vans will be powered by US Hybrid's powertrain with an estimated range of 220 miles per charge and will be compatible with high-power, DC fast charging currently used by AVTA.
|
AMED | Hot Stocks08:07 EST Amedisys to acquire Evolution Health, terms not disclosed - Amedisys announced that it has signed a definitive agreement to acquire Evolution Health, LLC, a division of Envision Healthcare, doing business as Guardian Healthcare, Gem City, and Care Connection of Cincinnati. Headquartered in Dallas, Texas, the company cares for more than 3,300 home health patients daily and employs more than 650 employees in 15 locations across Texas, Oklahoma and Ohio. Under the terms of the transaction, expected to close in the first half of 2022, Amedisys will acquire 100 percent of the ownership interests in Evolution Health. Once complete, this will increase Amedisys' home health access to more than 1.9 million Medicare enrollees and more than 690,000 Medicare Advantage enrollees in Texas, and more than 800,000 Medicare enrollees and more than 350,000 Medicare Advantage enrollees in Ohio. Post-closing, Amedisys will provide both home health and hospice services to six communities across Texas, including Dallas/Fort Worth, San Antonio and Houston, furthering our strategy to become the solution for those who want to age in place. The transaction adds greater scale to Amedisys' high-quality, nationwide network of 331 home health care centers. Post-closing, the combined home health operations will include 346 care centers in 34 states and the District of Columbia, with an average daily census of approximately 73,499 patients and approximately 11,236 home health employees.
|
ELYS | Hot Stocks08:06 EST Elys Game granted approval for Grand Central Restaurant and Sportsbook - Elys Game Technology announced that Grand Central Restaurant and Sportsbook in Washington D.C. has been granted approval by the DC Office of Lottery and Gaming, Regulation and Oversight Division to increase the number of authorized ticket window terminals and self-service betting kiosks. The expansion allows for increased traffic to each terminal improving customer experience and wager velocity.
|
TCON | Hot Stocks08:06 EST Tracon Pharmaceuticals announces initiation of Phase 2 trial of TRC102 - TRACON Pharmaceuticals announced that the National Cancer Institute, NCI, has initiated a randomized Phase 2 trial of TRC102 in combination with chemoradiation in patients with stage III non-squamous non-small cell lung cancer. The open-label two arm trial will enroll 78 patients and assess the benefit of adding TRC102 to current standard of care treatment of pemetrexed, cisplatin, and radiation therapy followed by consolidative durvalumab. The primary endpoint of the trial is progression free survival, PFS, and the trial is designed to detect an improvement in PFS at one year from 56% to 75%. Enrollment is expected to begin in June 2022 and results are expected in 2024. "We are pleased by the continued support of the National Cancer Institute for the development of TRC102 through our Cooperative Research and Development Agreement, including sponsorship of the initial randomized trial of TRC102," said Charles Theuer, M.D., Ph.D., President and CEO of TRACON. "The initiation of a randomized clinical trial of TRC102 marks an important milestone for the program."
|
AWK | Hot Stocks08:06 EST Missouri American Water invests $2.1M in Jefferson City's water system - To improve Jefferson City's water system, Missouri American Water is investing $2.1M to replace more than 9,300 feet of aging water mains. "Because our pipes are buried underground it can be easy to take our drinking water system for granted," said Missouri American Water President Rich Svindland. "Making investments to replace water mains as they reach the end of their useful life allows us to continue to provide clean, safe and reliable service for our customers in Jefferson City and around the state."
|
ATCO | Hot Stocks08:06 EST Atlas Corp.'s APR Energy extends partnership with California's IID - APR Energy, a wholly owned subsidiary of Atlas Corp, announced that it has extended a contract to provide approximately 75 MW of back-up energy for California's Imperial Irrigation District through 2022. The extension follows APR's successful execution of services with IID in 2021. APR's fast-track power solutions assist IID in maintaining frequency and providing backup capacity within its 6,471 square mile service territory, including all of Imperial County and parts of Riverside and San Diego counties.
|
TWIN | Hot Stocks08:05 EST Twin Disc sees $7M-$10M in 2022 capital expenditures - Jeffrey Knutson, Vice President - Finance, CFO, Treasurer and Secretary stated, "We repatriated approximately $8.9 million in cash from Switzerland associated with the fiscal 2022 first quarter sale leaseback of our Rolla facility, which we used to pay down long-term debt. As a result, total debt was $25.3 million at December 31, 2021, compared to $31.9 million at September 24, 2021, and $41.8 million at December 25, 2020. With strengthening order rates, we believe we are well positioned to reduce inventory levels and convert more of our balance sheet to cash in the coming quarters. We expect to allocate capital to initiatives focused on reducing debt and modernizing our operations, and we plan to invest $7 million to $10 million in capital expenditures during fiscal 2022."
|
PAE | Hot Stocks08:05 EST PAE-Perini awarded $63.8M AFCAP V task order at Qatar air base - PAE-Perini has been awarded a task order on the Air Force Contract Augmentation Program, AFCAP, V to provide civil engineer base operating support to the 379th Air Expeditionary Wing at the Al Udeid Air Base in Qatar. The total evaluated price is $63.8M if all options are exercised. PAE-Perini is a joint venture between PAE and Perini Management Services. The one-year AFCAP V CE BOS task order starting March 1, 2022, has four, 12-month options. Most of the 945 facilities operate in three different geographical areas of the base. On this task order, PAE-Perini will provide facility operations, maintenance and repair services.
|
CLST | Hot Stocks08:04 EST Catalyst Bancorp names Jacques Bourque as CFO - Catalyst Bancorp announced that Jacques Bourque, CPA, has been named CFO of the Company and Bank. Bourque joined the company as Treasurer in October 2021. Previously, he served as Senior Accountant for Home Bank, N.A., where he played a key role in financial reporting and analysis.
|
CG | Hot Stocks08:03 EST Rock Mountain, Olayan led group acquires 48% stake in PurposeBuilt Brands - Rock Mountain Capital, The Olayan Group and funds managed by global investment firm Carlyle, announced that a group led by Rock Mountain and Olayan has acquired a 48% stake in PurposeBuilt Brands, the proceeds of which were used to redeem Carlyle's position. TA Associates, an investor since 2019, and company management are rolling 100% of their equity and will hold a 52% ownership stake. PurposeBuilt Brands is a portfolio of leading specialty cleaning products for the consumer and commercial markets.
|
CPRI | Hot Stocks07:57 EST Capri Holdings jumps 10% to $68.00 after Q3 results, FY22 guidance top estimates
|
ABBV | Hot Stocks07:52 EST AbbVie reports Q4 adjusted gross margin 83.6% - On a GAAP basis, the gross margin ratio in the fourth quarter was 71%.
|
NAT | Hot Stocks07:51 EST Nordic American Tankers announces sale of Suezmax 'Nordic Mistral' - The company said, "On the NAT website, you will see our press release of July 28, 2021, referring to our program to adjust our fleet. Accordingly, we announced the sale of "Nordic Sirius" on October 6, 2021. We have now sold one more Suezmax under the program. The 2002 built "Nordic Mistral" has been sold. This transaction is fixed and firm. The vessel is planned for delivery to the new owner later in February. A price of about $30M has been achieved in total for these two vessels, reflecting their quality and strengthening NAT. Following the above transactions, Nordic American Tankers controls a fleet of 23 Suezmaxes - including 2 newbuildings for delivery in May and June this year."
|
ABBV | Hot Stocks07:47 EST AbbVie reports Q4 global Humira net revenues of $5.334B, up 3.5% - In Q4: Global Humira net revenues of $5.334 billion increased 3.5 percent on a reported and operational basis. U.S. Humira net revenues were $4.553 billion, an increase of 6.0 percent. Internationally, Humira net revenues were $781 million, a decrease of 9.1 percent on a reported basis, or 8.8 percent on an operational basis, due to biosimilar competition. Global Skyrizi net revenues were $895 million. Global Rinvoq net revenues were $517 million.Global net revenues from the hematologic oncology portfolio were $1.873 billion, an increase of 4.6 percent on a reported basis, or 4.7 percent on an operational basis. Global Imbruvica net revenues were $1.385 billion, a decrease of 2.7 percent, with U.S. net revenues of $1.114 billion and international profit sharing of $271 million. Global Venclexta net revenues were $488 million, an increase of 33.3 percent on a reported basis, or 34.0 percent on an operational basis.
|
ATI | Hot Stocks07:47 EST Allegheny Technologies authorizes $150M share repurchase - Allegheny Technologies has authorized the repurchase of up to $150M of its outstanding common stock. The stock repurchase program does not obligate the company to repurchase any specific number of shares and it may be modified, suspended, or terminated at any time by the board of directors without prior notice.
|
ABBV | Hot Stocks07:45 EST AbbVie CEO says 'entering 2022 with significant momentum' - "We delivered another year of outstanding performance in 2021 with double-digit revenue and EPS growth that were well above our initial expectations," said Richard Gonzalez, chairman and CEO, AbbVie. "We are entering 2022 with significant momentum and expect our diverse set of growth assets, robust pipeline and excellent execution to deliver continued strong performance this year and over the long term."
|
OLB | Hot Stocks07:38 EST OLB Group reports annual transaction volume run rate reaches $1.35B - OLB Group announced that the company's merchant services annual transaction volume run rate has reached $1.35B in transaction volume as a result of 28.5M transactions.
|
MGDPF | Hot Stocks07:38 EST Marathon Gold reports latest Berry drill results, 2022 exploration program - Marathon Gold reports the latest drill assay results from the Valentine Gold Project in central Newfoundland and to announce the Company's 2022 exploration plans. The latest drill results represent fire assay data from seventeen diamond drill holes completed as part of the 2021 in-fill drill campaign at the 1.5 kilometre long Berry Deposit. Following the 2021 exploration program, the board of directors approved a 2022 program of 50,000 meters of diamond drilling, focused on the Berry and Victory Deposits. Matt Manson, President and CEO, commented: "During 2021, we completed 74,000 metres of drilling at the Valentine Gold Project, including 58,200 metres at the Berry Deposit. In total, the inventory of drilling at Berry now stands at approximately 100,000 metres. Assays from sixty-two 2021 Berry drill holes, representing 16,700 metres, remain outstanding. Once received, we will commence the next Berry Mineral Resource estimate... Given the consistently good results received during the course of 2021, we are optimistic about the potential of Berry to add a meaningful quantity of future mineral resources to the Valentine Gold Project mine plan."
|
FOUN RBT | Hot Stocks07:37 EST Founder SPAC files registration statement in connection with Rubicon combination - Founder SPAC (FOUN) and Rubicon Technologies (RBT) announced that Founder filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on February 1, 2022. The Registration Statement contains a preliminary proxy statement/consent solicitation statement/prospectus in connection with the previously announced business combination between Founder and Rubicon. Although the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Rubicon and Founder, as well as the proposed business combination. Rubicon, a Lexington, Kentucky-based company, is an environmental innovator that utilizes its cloud-based technology and software platform to provide smart waste and recycling solutions for businesses and governments worldwide, via its network of more than 8,000 hauling and recycling partners across 20 countries. On December 15, 2021, Founder entered into a merger agreement with Rubicon. The combined company is expected to be listed on the New York Stock Exchange upon completion of the transaction, which is expected to occur in the second quarter of 2022, subject to approval by Founder's shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions. The transaction and related financings are expected to provide gross proceeds of approximately $432M to Rubicon, assuming no redemptions and prior to the payment of transaction expenses.
|
IR | Hot Stocks07:36 EST Ingersoll-Rand acquires Houdstermaatschappij Jorc for EUR 27M - Ingersoll Rand acquired Houdstermaatschappij Jorc for an all-cash purchase price of EUR 27M. Jorc will join the Industrial Technologies and Services, or ITS, segment. Jorc is a manufacturer of condensate management products, primarily condensate drains, oil/water separators and air-saving equipment. The company is based in Heerlen, Netherlands and has additional facilities in the U.S. and Slovenia. Jorc has approximately EUR 13M in 2021 annual sales and 2021 adjusted EBITDA margins in excess of the ITS segment.
|
JAZZ | Hot Stocks07:36 EST Jazz Pharmaceuticals completes sBLA submission for Rylaze - Jazz Pharmaceuticals has completed the submission of a Supplemental Biologics License Application - sBLA - to the FDA seeking approval for a Monday/Wednesday/Friday intramuscular dosing schedule for Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients one month and older who have developed hypersensitivity to E. coli-derived asparaginase. The submission will be reviewed under the Real-Time Oncology Review program, an initiative of FDA's Oncology Center of Excellence, and follows Rylaze's initial approval under the RTOR program in June 2021. The sBLA submitted by Jazz is supported by data from the three-cohort intramuscular administration part of the Phase 2/3 trial of Rylaze in adult and pediatric patients with ALL and LBL who have developed hypersensitivity to an E. coli-derived asparaginase. Initial results showed that Rylaze maintains a clinically meaningful level of nadir serum asparaginase activity greater than or equal to0.1 IU/mL at both 48 and 72 hours. The sBLA follows FDA approval of Rylaze in June 2021 under the RTOR program. Rylaze was also granted orphan drug designation for the treatment of ALL/LBL in June 2021.
|
CWH | Hot Stocks07:35 EST Camping World to acquire Big Daddy RV's in London, Kentucky, no terms - Camping World Holdings announced an agreement to acquire Big Daddy RV's in London, Kentucky. The acquisition is anticipated to close in late February and will be the company's third location in the state. "We continue to pursue dealership acquisitions to expand our market share," said Marcus Lemonis, CEO and Chairman of Camping World Holdings. "The Big Daddy RV's acquisition fills a void in our footprint and allows us to more effectively service our customer base and is an excellent way for us to kick off 2022 with continued exceptional growth." The facility, located at 325 County Farm Road, just off I-75, near the Daniel Boone National Forest will transition to the Camping World brand at closing. The SuperCenter will include a wide range of new and used RV's from top manufacturers in addition to a full assortment of RV and outdoor products and accessories.
|
BBWI | Hot Stocks07:35 EST Bath & Body Works raises annual dividend 33% to 80c per share - The company announced approval by the Board of Directors of certain actions with respect to capital structure, including: The authorization of a 33 percent increase in the company's annual dividend to 80c per share. The declaration of the company's quarterly dividend of 20c per share, payable on March 4, 2022, to shareholders of record as of Feb. 18, 2022.
|
CME | Hot Stocks07:34 EST CME Group reports January ADV up 28% to 24.6M contracts
|
BBWI | Hot Stocks07:34 EST Bath & Body Works announces $1.5B share repurchase authorization - The company announced approval by the Board of Directors of certain actions with respect to capital structure, including: The authorization of a new $1.5B share repurchase program, $1B of which we plan to execute through an accelerated share repurchase this week. This follows the completion of the company's previous $1.5B share repurchase authorization, with nearly $2B or approximately 10 percent of shares outstanding as of Jan. 30, 2021, repurchased in fiscal 2021.
|
BBI | Hot Stocks07:34 EST Brickell acquires exclusive global rights to portfolio of STING inhibitors - Brickell Biotech and Carna Biosciences announced that they have entered into a licensing agreement, whereby Brickell will have the exclusive, worldwide rights to develop and commercialize Carna's portfolio of novel, potent, and orally available Stimulator of Interferon Genes, STING, antagonists. "Our acquisition of Carna's next-generation STING inhibitors represents a tremendous opportunity to expand our presence in immunology and inflammation and bring forward new treatment options for patients in need," commented Robert Brown, Chief Executive Officer of Brickell. "We believe that this portfolio of preclinical STING inhibitors is complementary to our current development-stage pipeline of NCEs, which includes BBI-02, a potential first-in-class DYRK1A inhibitor program that is expected to enter a Phase 1 clinical study in the coming months. These assets position us with two promising and novel immunology targets and we look forward to advancing them further throughout this year." Under the terms of the license agreement, Brickell will make a one-time cash payment to Carna of $2.0M. In addition, Brickell will pay Carna success-based development, regulatory, and sales milestone payments of up to $258M. Carna is also eligible to receive tiered royalty payments ranging from mid-single digits up to 10% of net sales. Brickell will be responsible for all future development activities and expenses related to the STING inhibitor platform.
|
TGI | Hot Stocks07:33 EST Triumph Group to sell Stuart, Florida Aerostructures business to Daher Aerospace - Triumph Group announced that it has entered into a definitive agreement to sell its Stuart, Florida Aerostructures business to Daher Aerospace. The sale includes the Stuart, Florida business and the transfer of Stuart employees. The Stuart operation specializes in the assembly of large, complex metallic structures such as wing and fuselage assemblies, and has approximately 400 employees. Since 2016, Triumph divested 16 non-core businesses, including the Stuart business addressed in the announcement, as part of its transformation efforts to enhance shareholder value and position the company for long-term success. This transaction is subject to customary closing conditions and is expected to close in the first half of the calendar year. Terms were not disclosed.
|
THRX | Hot Stocks07:32 EST Theseus Pharmaceuticals granted FDA orphan drug designation for THE-630 - Theseus Pharmaceuticals announced that the U.S. FDA has granted orphan drug designation to the company's lead candidate THE-630, a small-molecule oral pan-variant KIT inhibitor, for the treatment of patients with advanced gastrointestinal stromal tumor.
|
WM | Hot Stocks07:23 EST Waste Management to raise dividend by 30c to $2.60 per share - The Board of Directors has indicated its intention to increase the annual dividend by 30c per share to $2.60, increasing estimated annual dividends paid to shareholders to $1.08 billion. This will be the 19th consecutive year of increases in the Company's per share dividend. The Board of Directors must separately approve and declare each dividend. In December 2021, the Board of Directors refreshed the Company's share repurchase authorization, allowing for the repurchase of up to $1.5 billion of the Company's common stock, signaling confidence in the Company's cash flow outlook and financial position.
|
XMTR | Hot Stocks07:21 EST Xometry announces pricing of $250M offering of convertible senior notes - Xometry announced the pricing of $250M aggregate principal amount of 1.00% Convertible Senior Notes due 2027 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Xometry has also granted the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $37.5M aggregate principal amount of Notes. The sale of the Notes to the initial purchasers is expected to close on February 4, 2022, subject to customary closing conditions. The Notes will be general unsecured obligations of Xometry and will accrue interest payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2022, at a rate of 1.00% per year. The Notes will mature on February 1, 2027, unless earlier converted, redeemed or repurchased. Xometry estimates that the net proceeds from the Offering will be approximately $241.9M to Xometry after deducting the initial purchasers' discounts and commissions and estimated Offering expenses payable by Xometry. Xometry expects to use the net proceeds from the Offering for working capital and general corporate purposes and for acquisitions of, or strategic investments in, complementary businesses, products, services or technologies.
|
NYT | Hot Stocks07:20 EST New York Times increases quarterly dividend, adopts $150M stock repurchase plan - The company's board of directors declared a 9c dividend per share on the company's Class A and Class B common stock, an increase of 2c from the previous quarter. The dividend is payable on April 21 to shareholders of record as of the close of business on April 6. The board of directors also approved a $150M Class A stock repurchase program. The new authorization replaces an existing authorization under which approximately $16.2M remained.
|
TPRFF | Hot Stocks07:19 EST GCM Mining announces high-grade drill results at El Silencio mine - GCM Mining announced multiple high-grade intercepts from the latest 79 diamond drill holes totaling 14,798 meters of the ongoing underground in-fill drilling campaign that is being carried out by the Company's Mine Geology Department at the El Silencio Mine at its Segovia Operations. This mine geology in-fill drilling campaign, which commenced in 2020 and is ongoing, is focused on resource definition within the underground mine developments of the El Silencio Mine and complements the results from the 2021 in-mine drilling programs being carried out by the Company's Exploration Team announced in the Company's press release on December 16, 2021. In particular, the continuation of multiple high-grade intercepts in the 1040 Vein discovered last year by this mine geology in-fill drilling campaign at the El Silencio Mine reaffirms the potential for the current and future development of this flagship mine. The best high-grade intercepts from these latest drill results at the El Silencio Mine include: 1040 Vein: 201.22 g/t Au and 109.8 g/t Ag over 0.36 meters; 1150 Vein: 61.24 g/t Au and 68.20 g/t Ag over 0.54 meters; and Manto Vein: 51.76 g/t Au and 174.7 g/t Ag over 0.44 meters. Serafino Iacono, Executive Chairman of GCM Mining, commented, "Our drilling programs at Segovia are continuing to provide us with outstanding results. In-fill drilling has consistently delivered evenly distributed high-grade results throughout the 1040 Vein, which is close to the mine workings currently in production. This will contribute to the expansion of mineral resources and will increase the mine life for the El Silencio Mine. We will be incorporating these results in our annual mineral reserve and resource updates expected to be announced in March 2022."
|
NYT | Hot Stocks07:18 EST New York Times sees FY22 capital expenditures $50M
|
NXTTF | Hot Stocks07:17 EST Lifeist Wellness streamlines company around wellness strategies - The company said, "Within cannabis, Lifeist's strategic focus is to be the pre-eminent value-added distribution platform and manufacturer of higher margin products serving the cannabis 2.0 consumer. The Company believes that these areas offer the greatest potential for growth and value creation for shareholders. As a distributor, CannMart has established supply agreements with provincial government cannabis control boards and retailing bodies in the provinces of Ontario, Alberta, British Columbia, Manitoba, New Brunswick and Saskatchewan, and most recently added Yukon, Northwest Territories and Nunavut, constituting access to approximately 73% of adult Canadians. It is now the trusted distribution partner for 10 LPs and 21 brands in addition to in-house brands Roilty and Mezzero and 3 licensed brands. Most recently CannMart added LPs including J2 Science, Embark Health, TorrCann, JMF Growers family and Loosh Brands to its growing list of partners and also added cannabis-cause brand TobaGrown under license agreement. Meanwhile, CannMart Labs began commercial production in November 2021 with live resin products and is now considering developing new formats to expand the portfolio of cannabis 2.0 products. Earlier this month, CannMart's cannabis 2.0 consumer-focused house brand "Roilty'' won the prestigious "Canadian LP Brand of the Year'' award at the 2021 ADCANN Awards, only months after the brand's initial launch. Collectively, CannMart's B2B revenue stream represented approximately 90% of Lifeist's cannabis revenue for the nine months ended August 31, 2021 and for the twelve months ended November 30, 2020, and has delivered substantially all of the revenue growth and gross margin contribution during each of these periods."
|
NYT | Hot Stocks07:17 EST New York Times sees Q1 total subscription revenue up 11%-15% - Sees Q1 adjusted operating costs up 18%-22%.
|
NXTTF | Hot Stocks07:16 EST Lifeist Wellness transfers B2C medical cannabis business to Medicibis - Lifeist Wellness announced a strategic move designed to continue to sharpen the Company's focus. The streamlining of the Company around wellness strategies with higher growth and profitability potential represents a continuation of a renewed commitment by Lifeist to create and return value to shareholders. "We were proud to be one of the first companies in Canada to enter the online business-to-consumer medical cannabis space and to provide high quality products to patients, but the time has come to realign our focus. The regulatory and consumer conditions for medical cannabis in Canada have evolved such that achieving success would require significant and ongoing investments without a growth trajectory and near-term returns to support it," commented Meni Morim, Lifeist's CEO. "Accordingly, we have moved decisively to realign all our resources on more promising near-term opportunities, particularly our cannabis B2B distribution and manufacturing businesses, and our recently-launched nutraceutical initiative, each of which enjoy a clearer path to growth with higher near-term profit potential." Daniel Stern, CEO of CannMart, added, "We have entered into an agreement with Medicibis, operators of Mendocannabis.ca to facilitate and complete the transfer of our registered medical patients to Medicibis and we are confident in Medicibis' ability to provide the same care and kindness we provided through our cannmart.com platform. CannMart's B2B recreational cannabis platform, which includes the distribution and logistics business together with CannMart Labs, is the overwhelming driver of our cannabis business. It is growing to be about 90% of our cannabis revenue and has been delivering substantially all of the gross margin contribution, making the B2C business less relevant and no longer core to our long-term strategy. Formalizing this shift enables CannMart to put resources where it can create the most value." Mendo will offer CannMart patients a discount of 10% on two orders of the new member's choice to further ease the transition. Also, If a patient's medical document is expired or is expiring this year, Mendo will cover the cost for renewal upon transfer to their platform.
|
CRVL | Hot Stocks07:15 EST CorVel appoints Jeff Gurtcheff as Vice President of Enterprise Comp - CorVel has named Jeff Gurtcheff as Vice President of Enterprise Comp. "As Vice President of Enterprise Comp, Gurtcheff will refine product vision and strategy related to corporate goals and manage resources responsible for regulatory compliance, claims handling, quality, and standards and procedures," the company said. Gurtcheff joined CorVel in 2019 as Vice President of National Accounts and Strategic Insights.
|
VLNS | Hot Stocks07:15 EST Valens launches strategic integration phase after acquisitive 2021 - Valens announced integration initiatives aimed at driving revenue growth and market share gains for each of its portfolio brands in their target markets, as well as margin improvement following an acquisitive 2021. As Valens now enters the 'Grow & Optimize' phases of its 'Launch, Grow, Optimize' strategy, the company will be focusing on four key pillars: driving revenue growth with a focus on Canadian recreational and U.S. health and wellness markets; capturing market share across its brand portfolio in product categories of focus that include flower, vape, pre-roll, edible, and beverage offerings in the premium, accessible premium, and value segments; seeking to generate increased gross margins and positive EBITDA margins through revenue growth and cost reduction and efficiency initiatives; creating shareholder value through operational performance, financial transparency, and increased trading liquidity. CEO Tyler Robson said, "As we redirect our focus to realizing the full package of targeted benefits from these acquisitions, we are now capturing the first wave of synergies through operational and organizational changes that we believe will not only improve our efficiencies but also drive the business towards becoming EBITDA positive in fiscal Q4 2022. I'm proud to say that we have identified $10M in annual cost efficiencies and expect to identify an additional $10M in the coming quarters through additional planned initiatives. Investors can expect to start to see some of the benefits of the first wave of efficiencies in fiscal 2Q22, with the majority of the impact being realized in the second half of the fiscal year. By the end of 2022, we expect to realize additional annual cost efficiencies of $10M through the continued optimization of internal processes, right-sizing of our cost structure and the realization of further synergies from our recent acquisitions. Incremental to the $20M of cost efficiencies, efforts to monetize surplus or unnecessary assets and tighter working capital management is anticipated to generate an additional $5M-$10M in cash over the coming quarters."
|
GILT | Hot Stocks07:14 EST Gilat Satellite announces launch of SkyEdge IV - Gilat Satellite Networks announced the launch of SkyEdge IV, a next generation satellite communication ground system, aiming to capture a leading position of the multibillion-dollar emerging VHTS market opportunity. SkyEdge IV will increase operational efficiencies due to scalable software centricity and provides VSAT backward compatibility to preserve SkyEdge II-c customer investment. Gilat's SkyEdge IV is a multi-orbit, multi-service platform built to work in harmony with software defined satellites and support cloud software defined network centric infrastructure. "Gilat is bringing to market SkyEdge IV, an unprecedented deep-tech software-centric platform that will make the future multibillion-dollar VHTS market opportunity a reality," said Hagay Katz, Gilat's Chief Product and Marketing Officer. "I am pleased to report that we have already secured significant orders for this leading platform."
|
FLGC | Hot Stocks07:12 EST Flora Growth seek Colombian FDA approval for cannabinoid-based product study - Flora Growth announced that the Company is seeking approval from INVIMA, the Colombian FDA, to begin research on their patent-pending, cannabinoid-based product, citing recent studies stating the possibility of cannabinoids to display viral inhibition. "We are honored to receive the advice and guidelines from INVIMA as we begin this exciting research process. The Flora Pharma division seeks to obtain evidence to support this product's use against SARS-CoV-2 and bring to market an effective, cannabinoid-based product," said Luis Merchan, President and CEO of Flora Growth. This diverse study will be conducted through Flora's research division, Flora Pharma, with formulation taking place in its GMP-certified Colombian lab. The research will look at all of the potential mechanisms of cannabinoids in preventing infection from the SARS-CoV-2 virus. This application comes on the heels of Colombia's new legislation requiring insurance companies to cover cannabis prescriptions. "I have worked on various aspects of SARS-CoV-2 research for the last two years, with a focus on cannabinoid therapeutics more broadly," said Dr. Annabelle Manalo-Morgan, scientist and head of Flora Pharma. "The intent of the study is to identify safe and efficacious cannabinoid products for use on SARS-CoV-2 thus allowing us to pursue the fastest path to market via a preventative immunomodulating product and to explore the possibility of use as a therapeutic. I believe the Flora team is best positioned to formulate, test and ultimately bring to the market this kind of novel product offering."
|
VIEW | Hot Stocks07:12 EST View Inc. announces third Durst skyscraper to use View Smart Windows - View announced that its smart windows have been installed at Sven, a 67-story, 958-unit luxury multifamily skyscraper in Long Island City by The Durst Organization. Sven is the tallest residential building in North America to feature smart windows. "Durst selected View Smart Windows to enhance energy-efficiency, optimize natural light, and provide residents with continuous outdoor views," the company said. "View is on a mission to transform all buildings into smart, healthy, and sustainable occupant experiences," added Dr. Rao Mulpuri, CEO of View. "We are gaining significant traction in the multi-family sector and are thrilled to partner with Durst to bring the game-changing benefits of our technology to residents of Sven."
|
BABYF | Hot Stocks07:12 EST KeHE Distributors expands Else Kids Nutrition product line - ELSE NUTRITION HOLDINGS announced that following the launch and performance of Else Toddler Nutrition at retailers serviced by KeHE Distributors, 4 new Else Kids Nutrition Shake Products are being added to KeHE's distribution. Else Kids Plant-Based Complete Nutrition for Kids will soon be available at retailers serviced by KeHE. This sets a potential distribution pathway to nearly 30,000 retail outlets. The first shipment of Else Vanilla and Chocolate is underway with Chia Mango and Chia Banana to be hopefully available later this quarter. Else Nutriton will soon present its full line of products to KeHE partners at KeHE summer show in New Orleans early Feb 2022.
|
ISO TCHBF | Hot Stocks07:10 EST IsoPlexis appoints Ou as President/General Manager, APAC region - IsoPlexis (ISO) announced the opening of its first office in the Asia-Pacific, APAC, region headed by Jason Ou as President/General Manager, APAC Region. "In this role, Ou will further advance IsoPlexis' growth in the APAC region, bolstered by a new office facility in Shanghai that will focus primarily on sales and technical support," the company said. Ou joined IsoPlexis from Tecan (TCHBF), a global provider of automated workflow solutions in the life science and clinical diagnostics markets.
|
SV | Hot Stocks07:10 EST Spring Valley Acquisition Corp., NuScale satisfy contingency for $30M PIPE - NuScale Power and Spring Valley Acquisition Corp. announced that the previously disclosed contingency with respect to $30M of Samsung C&T Corporation's PIPE investment has been satisfied.
|
SSNLF | Hot Stocks07:10 EST Samsung Bioepis announces Health Canada approval of ONTRUZANT - Samsung Bioepis announced that Health Canada has approved ONTRUZANT, a biosimilar referencing Herceptin, for the treatment of adults with Early Breast Cancer, Metastatic Breast Cancer and metastatic gastric cancer. ONTRUZANT is Samsung Bioepis' fifth biosimilar approved for the use in Canada following BRENZYS in August 2016, RENFLEXIS in December 2017, HADLIMA in May 2018, AYBINTIO in November 2021. ONTRUZANT will be commercialized in Canada by Organon. The Health Canada approval was based on a comprehensive data package and totality of evidence which included analytical, pharmacokinetic and clinical data, as well as pharmacology and toxicology data. The data proved that ONTRUZANT and reference trastuzumab are highly similar with no clinically meaningful difference.
|
TARS... | Hot Stocks07:08 EST Tarsus finishes Phase 3 Saturn-2 trial enrollment, secure $175M credit facility - Tarsus Pharmaceuticals (TARS) announced it has completed enrollment of Saturn-2, the company's second pivotal Phase 3 trial of TP-03 for patients with Demodex blepharitis and executed a $175M credit facility with Hercules Capital (HTGC) and Silicon Valley Bank (SIVB). "We are delighted Saturn-2 has completed enrollment with 408 patients during these challenging times, which speaks to the urgent need for an effective treatment for people living with Demodex blepharitis. We are committed to developing a solution for this disease as rapidly as possible and expect to share topline results from Saturn-2 in April, which, if positive, will be followed by a New Drug Application for TP-03 planned this year," said Bobak Azamian, M.D., Ph.D., President and Chief Executive Officer of Tarsus. "We are also grateful to secure this non-dilutive $175 million credit facility, providing Tarsus with significant financial flexibility to drive our business growth as we continue to pioneer the treatment landscape for patients with Demodex blepharitis and other important diseases," said Dr. Azamian. "With these developments, we are on track to advance and expand our pipeline, including delivering pivotal Phase 3 data from Saturn-2, submitting the TP-03 NDA for Demodex blepharitis, and if approved, be well-positioned for our expected commercial launch of TP-03 next year."
|
WNC | Hot Stocks07:08 EST Wabash announces rebranding of corporation - Wabash announced it has rebranded the corporation and its portfolio of brands under one, powerful Wabash brand that unites the company's products and services, employees, customers and business partners. Wabash will no longer go to market as Wabash National or with certain trade or brand names that it acquired over the last 16 years, including Benson, Brenner, Bulk Tank, Supreme, Transcraft and Walker. The company and its industry-leading van trailers, platform trailers, tank trailers, truck bodies, process systems, and parts and services will be rebranded and marketed as Wabash. In addition to the rebrand, Wabash is also introducing the brand name for its proprietary molded structural composite used in refrigerated transportation: EcoNex Technology. EcoNex Technology, formerly referred to as MSC Technology, is one of the most environmentally conscious materials in the transportation market, designed to advance sustainability throughout the transportation, logistics and distribution industry. This technology has already been recognized in the industry with several awards for advancing sustainability in commercial transportation. The company's rebrand includes the launch of its new website at OneWabash.com. Wabash will remain listed on the New York Stock Exchange under the ticker symbol WNC. The rebrand and elimination of legacy sub-brands does not change legal entities of the company, nor affect contracts, terms, or conditions in place with customers, dealers, suppliers or other stakeholders.
|
ONCY RHHBY | Hot Stocks07:08 EST Oncolytics and Roche's combination in pancreatic cancer shows positive safety - Oncolytics (ONCY) announced the completion of the three-patient safety run-in for the pancreatic cancer cohort of the phase 1/2 GOBLET study following evaluation by the study's Data Safety Monitoring Board. The DSMB noted no safety concerns in these patients and recommended the study proceed as planned. The safety run-in for the trial's third-line metastatic colorectal cancer cohort remains ongoing. The GOBLET study is designed to evaluate the safety and efficacy of pelareorep in combination with Roche's (RHHBY) anti-PD-L1 checkpoint inhibitor atezolizumab in patients with metastatic pancreatic, metastatic colorectal, and advanced anal cancers. The study remains ongoing and is expected to enroll patients at 14 clinical trial sites across Germany. The GOBLET study's pancreatic cancer cohort extends previously reported clinical data demonstrating the synergy and anti-cancer activity of pelareorep combined with checkpoint inhibition in pancreatic cancer patients who progressed after first-line treatment. It also builds on prior early clinical data that showed a greater than 80% increase in median progression-free survival in pancreatic cancer patients with low levels of CEACAM6 expression who received pelareorep in combination with chemotherapy. In addition to evaluating the safety and efficacy of pelareorep-atezolizumab treatment, GOBLET also seeks to demonstrate the potential of CEACAM6 and T cell clonality as predictive biomarkers, which may increase the likelihood of success of future registrational studies by allowing selection of the most appropriate patients.
|
BRAG | Hot Stocks07:08 EST Bragg Gaming names Lara Falzon COO - Bragg Gaming announced that it has appointed Lara Falzon, an accomplished iGaming executive and member of the Company's Board of Directors since March 1, 2021, to the new position of President and Chief Operating Officer. Ms. Falzon brings more than 10 years of industry experience to the new role, includif President and ng a significant track record of managing and structuring several multi-billion-dollar gaming transactions. As Chief Operating Officer, Ms. Falzon will be responsible for the primary oversight of the Company's day-to-day operational performance and will help guide the ongoing execution of Bragg's growth-focused strategies. She will also be responsible for fostering company-wide success-oriented accountability. Commenting on Ms. Falzon's appointment, Bragg's Interim Chief Executive Officer and Chairman of the Board, Paul Godfrey, said, "Lara's skill set and significant gaming industry accomplishments will serve to drive further improvements in our day-to-day operations, continued progress against our strategic initiatives, and overall financial growth. We look forward to benefiting from her oversight and guidance of our business practices and objectives as we continue to execute on our global growth strategy."
|
CPLP | Hot Stocks07:07 EST Capital Product Partners appoints Spyros Leoussis as CCO - The company said, "We are pleased to announce Mr. Spyros Leoussis has been appointed as Chief Commercial Officer of the Partnership, effective January 24, 2022. Notably, Mr. Leoussis brings 18 years of global experience in the LNG shipping and finance industries. He currently serves as Business Development Director of Capital Gas Ship Management Corp. and has previously worked as Head of Planning and Analysis for Nakilat, the largest LNG shipowner in the world and as Senior Consultant for the Treasury of National Bank of Greece."
|
ODFL | Hot Stocks07:06 EST Old Dominion boosts dividend 50% to 30c per share - The Company's Board of Directors has declared a first-quarter dividend of $0.30 per share, payable on March 16, 2022, to shareholders of record at the close of business on March 2, 2022. This dividend represents a 50.0% increase to the quarterly cash dividend paid in the first quarter of 2021.
|
KIM | Hot Stocks07:05 EST Kimco Realty raises quarterly dividend 11.8% to 19c per share - The quarterly cash dividend on common shares, which is based on projected REIT taxable income, is payable on March 24 to shareholders of record on March 10.
|
AVIR | Hot Stocks07:05 EST Atea Pharmaceuticals announces publication on bemnifosbuvir - Atea Pharmaceuticals announced that new data highlighting bemnifosbuvir were published in the peer-reviewed journal, Nature Communications, in an article titled, "A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase." The published data demonstrate that bemnifosbuvir's mechanism of action has the potential to create a high barrier to resistance with broad antiviral activity across SARS-CoV-2 variants of concern. In Phase 2 clinical trials, bemnifosbuvir has demonstrated rapid and sustained antiviral activity in high-risk patients with COVID-19 and has been shown to be generally safe and well tolerated. "With its unique dual mechanisms, demonstrated safety and broad antiviral activity across SARS-CoV-2 variants of concern, we strongly believe in bemnifosbuvir's potential to play an important role in the treatment of COVID-19," said Jean-Pierre Sommadossi, Ph.D., Founder and Chief Executive Officer of Atea Pharmaceuticals. "The data published today provide us with further confidence that we can meet the evolving needs of patients with COVID-19." These new data demonstrate that the SARS-CoV-2 nsp12-nsp7-2 minimal replication transcription complex can promote two reactions essential to virus growth: grafting nucleotides onto viral proteins nsp8 and nsp9 by means of the NiRAN domain and de novo synthesis of dinucleotide primers by RdRp in a NiRAN-independent fashion.
|
SR | Hot Stocks07:04 EST Spire sees FY22 CapEx $570M - The company said, "We remain confident in our long-term ability to grow NEE per share 5-7% given our growth strategy, expectations of reasonable regulatory outcomes, and planned capital investment in infrastructure upgrades, innovation and new business. Our targeted capital investment for the 5-year period through fiscal 2026 remains $3.1 billion, and this level of investments is anticipated to drive 7-8% rate base growth for our utilities. Capital expenditures for fiscal 2022 are targeted at $570 million. Our fiscal 2022 NEE is expected to fall in the range of $3.70 to $4.00 per share, reflecting the Missouri rate order and the uncertainty surrounding recovery of overhead costs as noted above."
|
AGFY | Hot Stocks07:03 EST Agrify acquires Lab Society for $8M in cash, stock transaction - Agrify announced it has acquired Lab Society, a company in distillation and solvent separation solutions for the cannabis extraction industry. "The ability to take cannabis compounds distilled into their pure forms, and then recombine them into specific, purposeful end-products could have significant potential for the pharmaceutical industry in the future," the company said. "We are ecstatic to add Lab Society to our portfolio of high-quality extraction solutions," said Raymond Chang, Chairman and CEO of Agrify. "By owning the top key solutions that produce the highest quality and the widest range of extracted cannabis products at scale, we expect it will provide Agrify with a significant competitive differentiation, enhanced customer value-add, superior industry leadership position and significant growth opportunities globally." Agreement Details: The purchase price for Lab Society was $8M, consisting of $4M in cash and $4M in unregistered shares of Agrify common stock, subject to adjustments as set forth in the definitive agreement. There is also an additional earnout opportunity of up to $3.5M if the revenue generated from Lab Society's products reaches certain milestones in 2022 and 2023. The definitive agreement includes customary representations, warranties, and covenants regarding Lab Society and Agrify.
|
EMR | Hot Stocks06:58 EST Emerson Electric sees FY22 operating cash flow $3.8B, free cash flow $3.1B - Sees FY22 share repurchase $250M-$500M; Dividend $1.2B.
|
MMNFF AAWH | Hot Stocks06:50 EST MedMen seeks subpoeana of Hochul's office over sale with Ascend Wellness - Earlier last month, MedMen (MMNFF) accused New York Governor Kathy Hochul's administration of using improper influence in December to seal Ascend Wellness' (AAWH) deal to buy a majority of MedMen's dispensary chains after Ascend President Andrew Brown allegedly attended a fundraiser hosted by Governor Hochul, according to New York Supreme Court records. On January 31, MenMen wrote a request to Judge Margaret Pui Yee Chan for permission to subpoena the Office of Governor Kathy Hochul. Among other things, MedMen wants to know who attended and contributed to the fundraising event. Reference Link
|
RRD | Hot Stocks06:48 EST Strategic Party withdraws $11.50 non-binding proposal to acquire RRD - R.R. Donnelley & Sons Company announced that the unsolicited non-binding and conditional "Alternative Acquisition Proposal", as defined in the company's previously announced definitive merger agreement with affiliates of Chatham Asset Management, dated as of December 14, 2021 from a strategic party to acquire all of the outstanding shares of RRD's common stock for $11.50 per share in cash has been withdrawn. The Strategic Party did not provide specific reasons for its withdrawal. The company remains subject to the Chatham Merger Agreement, pursuant to which Chatham will acquire all of the RRD common stock not already owned by affiliates of Chatham for $10.85 per share in cash. As previously announced, the company has scheduled the special meeting of stockholders for purposes of voting on the Chatham Merger Agreement and the transactions contemplated thereby for February 23, 2022. The Chatham Merger Agreement has been unanimously approved by the RRD Board of Directors and the Board again reaffirms its recommendation that stockholders vote for the Chatham Merger Agreement and the transactions contemplated thereby. The company urges stockholders to vote their shares today to approve the Chatham Merger Agreement and the transactions contemplated thereby at the company's upcoming special meeting. The Chatham transaction is expected to close in the first quarter of 2022, subject to customary closing conditions, including the approval of RRD stockholders.
|
GIB | Hot Stocks06:45 EST CGI Inc. renews NCIB - CGI announced that its board of directors has authorized the renewal of its Normal Course Issuer Bid, or NCIB, subject to approval by the Toronto Stock Exchange, or TSX. CGI's management and board of directors believe that the purchase for cancellation of the company's Class A subordinate voting shares is a proper use of funds, and the NCIB will provide the flexibility to purchase Class A Shares from time to time as the company considers it advisable, as part of its efforts to increase shareholder value. Under the terms of the NCIB, subject to TSX approval, the company may purchase for cancellation on the open market through the facilities of the TSX and the New York Stock Exchange and through alternative trading systems, as well as outside the facilities of the TSX pursuant to exemption orders issued by securities regulators, up to 18,781,981 Class A Shares, representing approximately 10% of the company's public float as of the close of business on January 24.
|
NILE BTC | Hot Stocks06:41 EST BitNile reports January Bitcoin production and mining results - BitNile (NILE) published an unaudited update on Bitcoin (BTC) production and miner installation. BitNile's Bitcoin mining production is currently operating at an estimated annualized run rate of 327.26 Bitcoin based on current market conditions, including a mining difficulty of 26.6 trillion. BitNile has received 2,185 S19j Pro Antminers with 1,860 active miners generating a combined processing power of approximately 189 petahashes per second. During the month of January 2022, BitNile self-mined 27.19 Bitcoin. To date, BitNile has mined a total of 74.98 Bitcoin. As previously planned, BitNile completed the sale of the 1,600 S9 Antminers at the Indiana location. BitNile has entered into purchase agreements with Bitmain Technologies for a total of 20,600 Bitcoin miners, including 4,600 environmentally friendly S19 XP Antminers that feature a processing power of 140 terahashes per second and 16,000 S19j Pro Antminers that feature a processing power of 100 TH/s. Once all 20,600 miners are fully deployed and operational, BitNile is expected to achieve mining production capacity of approximately 2.24 exahashes per second.
|
NGL | Hot Stocks06:38 EST NGL Energy Partners partners with XRI Holdings for produced water management - NGL Energy Partners announced a collaboration with XRI Holdings to advance full cycle produced water management across operations in the Delaware Basin. NGL owns and operates the largest integrated produced water pipeline system in the Basin where it currently manages over 1.8 million barrels per day. XRI is the largest produced water recycling company in the Permian Basin, managing total water volumes in excess of 1.2 million barrels per day. The flexible, non-exclusive nature of this joint effort allows each company to continue to operate produced water reuse and recycling activities independent of one another.
|
HUM | Hot Stocks06:36 EST Humana targets $1B of additional value through cost savings - In order to create capacity to fund growth and investment in its Medicare Advantage business and further expansion of its Healthcare Services capabilities in 2023, Humana is committing to drive $1B of additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. It is the company's intention that these efforts will span several areas, including the following: Performing a critical review of ongoing strategic initiatives across the company, intending to further focus investments on priorities where Humana has the greatest conviction of significant value potential, driving further organizational efficiencies by optimizing the company's workforce to increase speed, agility, and the pace at which Humana must work as a large, integrated healthcare organization, reducing and optimizing third-party spend, including significantly rationalizing its real estate portfolio, and driving greater operational efficiencies across the organization by modernizing, streamlining, and improving processes through automation and digital advancement. As a result of this work, the company anticipates that it will experience certain one-time restructuring charges in FY 2022 that will impact its GAAP results, but will be adjusted for non-GAAP purposes.
|
IDXX | Hot Stocks06:35 EST Idexx Laboratories reports Q4 EPS $1.89, consensus $1.71 - Reports Q4 revenue $801.09M, consensus $781.83M. "IDEXX had a strong finish to an exceptional 2021, as busy veterinary customers responded positively to our highly differentiated diagnostic testing and information management platforms," said Jay Mazelsky, IDEXX's CEO. "We're pleased to see veterinarians look to IDEXX solutions to support their passion to improve patient care and to run their practices more efficiently at a time when they have never been busier. This has resulted in continued high CAG Diagnostics recurring revenue growth across our major regions and record levels of premium instrument placements, with solid gains across our major in-clinic platforms. As a Purpose-driven company focused on improving the health and well-being of pets, people and livestock, our outstanding results reflect the high levels of execution across the IDEXX organization through the challenges of the COVID-19 pandemic. We are well-positioned to build on this momentum moving forward and to address the still significant untapped potential for companion animal healthcare globally."
|
DHI | Hot Stocks06:32 EST D.R. Horton backs 2022 homes closed guidance of 90,000-92,000 - The company reaffirms its previously issued fiscal 2022 guidance for other metrics including: Homes closed between 90,000 homes and 92,000 homes; Income tax rate of approximately 24%; Outstanding share count at the end of fiscal 2022 approximately 2% lower than at the end of fiscal 2021.
|
MPLX | Hot Stocks06:19 EST MPLX reports Q4 EPS 78c, consensus 75c - Reports Q4 revenue $2.73B, consensus $2.47B. "In 2021, our focus on strict capital discipline and lowering the cost structure as well as solid operational performance contributed to strong cash generation," said Michael Hennigan, MPLX chairman, president, and chief executive officer. "This year MPLX returned approximately $4.2 billion of capital to unitholders through both distributions and unit repurchases."
|
MPC | Hot Stocks06:16 EST Marathon Petroleum sees FY22 capital spending $1.74B
|
LOGC | Hot Stocks06:11 EST LogicBio Therapeutics provides update on LB-001 clinical development program - LogicBio Therapeutics provided an update on the LB-001 clinical development program. The FDA has notified the company that its Phase 1/2 SUNRISE clinical trial of LB-001 in pediatric patients with methylmalonic acidemia, or MMA, has been placed on clinical hold. The company will host a conference call and webcast this morning to discuss this update. To date, four patients have been dosed in the SUNRISE trial with LB-001, LogicBio's investigational, single-administration, adeno-associated virus, or AAV, genome editing therapy. In accordance with the FDA-cleared protocol, the first two patients dosed were in the older age group and received 5 x 1013 vg/kg of LB-001. These first two patients are doing well, have not experienced drug-related serious adverse events, or SAEs, and are being monitored in accordance with the protocol. As previously disclosed, the third patient dosed in the SUNRISE trial, who received 5 x 1013 vg/kg of LB-001 and is in the younger age group, experienced a drug-related SAE, which was categorized as a case of thrombotic microangiopathy, or TMA. TMA has been previously reported in association with other AAV genetic therapies. The patient was hospitalized and responded well to intravenous fluids and parenteral nutrition. Following this SAE, the company implemented additional safety measures in the SUNRISE trial, and reported the SAE to the FDA and the Data Safety Monitoring Board for the trial, or DSMB. In December 2021, the company announced that the SAE experienced by the third patient had resolved. In January, the fourth patient dosed in the SUNRISE trial, who received 5 x 1013 vg/kg of LB-001 and is in the younger age group, experienced a drug-related SAE, which was categorized as a case of TMA. The patient is being closely followed by the patient's care team and has been steadily improving. The company reported the SAE to the FDA and the DSMB. The FDA subsequently notified the company that the SUNRISE trial has been placed on clinical hold. LogicBio will be working closely with the FDA and the DSMB to determine the next steps for the SUNRISE trial and the LB-001 program. Until the company has more clarity regarding the impact of the clinical hold, LogicBio is suspending guidance on the timing of announcing interim data for the SUNRISE trial.
|
MDT | Hot Stocks06:08 EST Medtronic announces first procedure performed with Hugo RAS system - Medtronic and OLV Hospital Aalst announced that the first clinical procedure in Europe was performed with the Hugo robotic-assisted surgery, or RAS, system. The robotic prostatectomy was performed by Alexandre Mottrie, head of urology at OLV Hospital in Aalst, Belgium, and chief executive officer and founder of the Belgium-based ORSI Academy, a multidisciplinary center for training, research and development, and data analysis to improve minimally invasive surgery best practices.
|
KW GS | Hot Stocks06:05 EST Kennedy Wilson and Goldman Sachs Asset Management acquire Seattle community - Kennedy Wilson (KW) and the Real Estate business within Goldman Sachs (GS) Asset Management have acquired Coppins Well, a 236-unit high-rise apartment community in Seattle, Washington for $106.5M, excluding closing costs. Completed in 2012, the 17-story building complements Kennedy Wilson's multifamily presence in Washington, which now exceeds 10,000 units. Kennedy Wilson has a 30% ownership interest in Coppins Well, which the partnership acquired with a total equity investment of $44M and a $66M loan, and currently generates $3.5M of net operating income.
|
FREY | Hot Stocks06:02 EST Freyr Battery enters nine frame agreements with key suppliers - Freyr Battery has entered into nine frame agreements with key suppliers for the supply of battery materials required for the Customer Qualification Plant being built in Mo i Rana, Norway. The remaining four frame agreements are in the final stages of negotiations. These frame agreements will be the basis for supply of raw materials to the CQP as well as to Gigafactories 1 and 2. Freyr is on track to start the initial sample production of lithium iron phosphate battery cells in its CQP in the second half of 2022. The frame agreements described above will form the legal basis for the supply of the facility with cathode active material, anode active material, separators, electrolyte, Al-foil, Cu-foil, and insulation material, comprising more than 90% of the material required on both a value and volume basis. The next step will be to agree on volume and price for each raw material, after which Freyr will be in a position to issue purchase orders. FREYR has also entered into an agreement for localized supply of raw materials in the Nordics with Glencore, as well as a Heads of Terms for a JV with the Taiwanese company Aleees to establish giga production of LFP cathode materials in the region. This JV is expected to address the need to establish competitive European LFP cathode supply, which is currently primarily sourced from major producers in China. Both agreements demonstrate FREYR's progress in delivering the supply of localized, low-carbon raw materials for Gigafactory battery-cell production in Norway and Finland.
|
ENSG | Hot Stocks06:02 EST Ensign Group acquires two skilled nursing facilities in California - Ensign Group acquired the operations of the following skilled nursing facilities in California: Arrowhead Springs Healthcare, a 119-bed skilled nursing facility located in San Bernardino, California; and Desert Mountain Care Center, a 99-bed skilled nursing facility located in Indio, California. The acquisitions were effective February 1. The acquisition of Arrowhead Springs Healthcare includes the real estate and operations at the facility. Desert Mountain Care Center will be subject to a long-term, triple net lease. These acquisitions bring Ensign's growing portfolio to 248 healthcare operations, 22 of which also include senior living operations, across thirteen states.
|
ELMS | Hot Stocks05:48 EST Electric Last Mile reports preliminary cash, cash equivalents $132M-$142M - The company expects to report on a preliminary, unaudited basis that it had approximately $132M-$142M in cash and cash equivalents, which includes $25M to 30M in restricted cash, as of December 31, 2021.
|
ELMS OUST | Hot Stocks05:47 EST Electric Last Mile Solutions CEO, chairman resign after investigation of board - Electric Last Mile Solutions (ELMS) announced that Shauna McIntyre, a member of the company's board of directors, has been appointed as interim CEO and president, succeeding James Taylor, who has resigned from his role as CEO and a member of the board. In addition, Brian Krzanich has been appointed non-executive chairman of the board, replacing Jason Luo, who has also resigned from his position as executive chairman of the board. The departures follow an investigation conducted by a special committee of the board of directors. McIntyre most recently served as president of Ouster (OUST), following over 25 years working with automotive OEMs. On November 25, 2021, the company's board formed an independent special committee to conduct an inquiry into certain sales of equity securities made by and to individuals associated with the company, the legal, disclosure and tax consequences of those transactions, and other issues that arose in connection those sales. Based on the special committee's investigation, the company has concluded that in November and December 2020, shortly before the company's December 10, 2020 announcement of a definitive agreement for a business combination with Forum Merger III Corporation, certain Electric Last Mile Inc. executives purchased equity in the company at substantial discounts to market value without obtaining an independent valuation. Taylor purchased equity in these transactions. Luo participated in these and other transactions and directly or indirectly purchased and sold equity in such transactions. In addition, on January 26, on the basis of the special committee investigation, the board concluded that the company's previously issued consolidated financial statements should be restated and, therefore, should no longer be relied upon. The financial statements in question cover the period as of December 31, 2020, the period from August 20, 2020 through December 31, 2020, the six months ended June 30, and the nine months ended September 30, 2021. In connection with this conclusion, the company, together with its advisors, is evaluating the accounting and treatment of certain equity issuances to executive officers. Although the company cannot, at this time, estimate when it will file its restated financial statements for such periods, it is pursuing completion of the restatement, including with respect to an evaluation of the Company's financial statement reserves for tax payments and contingencies.
|
MCO | Hot Stocks05:20 EST Moody's to acquire majority stake in Global Credit Rating, terms undisclosed - Moody's announced that it has agreed to acquire a majority stake in Global Credit Rating, or GCR. GCR is a credit rating agency in Africa with operations spanning the continent, including in South Africa, Nigeria, Senegal, Kenya, and Mauritius. Moody's is engaging with a South Africa-based empowerment partner who will provide local strategic support through substantial equity participation and representation on the GCR South Africa board. Following the transaction, GCR will continue to develop its own rating methodologies, issue its own credit ratings, and maintain a separate management team. The transaction is subject to customary regulatory approvals. The terms of the transaction were not disclosed, and it will be funded with cash on hand. The transaction is expected to close in Q2 and will not have a material impact on Moody's 2022 financial results.
|
BTG | Hot Stocks05:16 EST B2Gold receives exploration permit from Mali government - B2Gold announced that the Government of Mali has recently granted B2Gold's Malian subsidiary a new exploration permit covering the same perimeter as the Menankoto permit, which together with the Bantako North permit comprises the Anaconda area, located 20 kilometers from the Fekola Mine.
|